| UNC0638, Alternative-names: , CAS# 1255580-76-7, Formula: C30H47N5O2, MWT: 509.7265, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Autophagy, Target: Histone Methyltransferase;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| TG003, Alternative-names: , CAS# 719277-26-6, Formula: C13H15NO2S, MWT: 249.3287, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| NMS-873, Alternative-names: , CAS# 1418013-75-8, Formula: C27H28N4O3S2, MWT: 520.6662, Solubility: DMSO: 20.5 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: p97, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| BMS-303141, Alternative-names: , CAS# 943962-47-8, Formula: C19H15Cl2NO4S, MWT: 424.2977, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: ATP Citrate Lyase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tolrestat, Alternative-names: AY-27773, CAS# 82964-04-3, Formula: C16H14F3NO3S, MWT: 357.3475, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Aldose Reductase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Dofequidar (fumarate), Alternative-names: MS-209, CAS# 153653-30-6, Formula: C34H35N3O7, MWT: 597.6576, Solubility: DMSO: ≥ 56 mg/mL, Clinical_Information: Phase 1, Pathway: Membrane Transporter/Ion Channel, Target: P-glycoprotein, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dofequidar, Alternative-names: , CAS# 129716-58-1, Formula: C30H31N3O3, MWT: 481.5854, Solubility: 10 mM in DMSO, Clinical_Information: Phase 1, Pathway: Membrane Transporter/Ion Channel, Target: P-glycoprotein, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| TCS PIM-1 1, Alternative-names: SC 204330, CAS# 491871-58-0, Formula: C18H11BrN2O2, MWT: 367.1961, Solubility: DMSO: ≥ 52 mg/mL, Clinical_Information: No Development Reported, Pathway: JAK/STAT Signaling, Target: Pim, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Antipyrine, Alternative-names: Phenazone;Phenazon, CAS# 60-80-0, Formula: C11H12N2O, MWT: 188.2258, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| L-Arginine, Alternative-names: (S)-(+)-Arginine, CAS# 74-79-3, Formula: C6H14N4O2, MWT: 174.201, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Phase 4, Pathway: Immunology/Inflammation, Target: NO Synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| L-Arginine (hydrochloride), Alternative-names: (S)-(+)-Arginine hydrochloride, CAS# 1119-34-2, Formula: C6H15ClN4O2, MWT: 210.6619, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: NO Synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Azatadine, Alternative-names: , CAS# 3964-81-6, Formula: C20H22N2, MWT: 290.4021, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Azatadine (dimaleate), Alternative-names: Azatadine maleate, CAS# 3978-86-7, Formula: C28H30N2O8, MWT: 522.5464, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Lithocholic acid, Alternative-names: 3α-Hydroxy-5β-cholanic acid, CAS# 434-13-9, Formula: C24H40O3, MWT: 376.5726, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Olsalazine (Disodium), Alternative-names: , CAS# 6054-98-4, Formula: C14H8N2Na2O6, MWT: 346.2027, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Toltrazuril, Alternative-names: , CAS# 69004-03-1, Formula: C18H14F3N3O4S, MWT: 425.3817, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Sertraline (hydrochloride), Alternative-names: , CAS# 79559-97-0, Formula: C17H18Cl3N, MWT: 342.6905, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Escitalopram, Alternative-names: (S)-Citalopram;S-(+)-Citalopram, CAS# 128196-01-0, Formula: C20H21FN2O, MWT: 324.3919432, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Escitalopram (oxalate), Alternative-names: (S)-(+)Citalopram oxalate, CAS# 219861-08-2, Formula: C22H23FN2O5, MWT: 414.4268232, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tinidazole, Alternative-names: , CAS# 19387-91-8, Formula: C8H13N3O4S, MWT: 247.27152, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Guanidine (hydrochloride), Alternative-names: Guanidinium chloride;Aminoformamidine Hydrochloride, CAS# 50-01-1, Formula: CH6ClN3, MWT: 95.53144, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50g |
| Cladribine, Alternative-names: 2-Chloro-2′-deoxyadenosine;CldAdo;2CdA, CAS# 4291-63-8, Formula: C10H12ClN5O3, MWT: 285.687, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Adenosine Deaminase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Imiquimod, Alternative-names: R 837, CAS# 99011-02-6, Formula: C14H16N4, MWT: 240.3036, Solubility: DMSO: 2.38 mg/mL (Need ultrasonic and warming), Clinical_Information: Launched, Pathway: Autophagy;Immunology/Inflammation, Target: Autophagy;Toll-like Receptor (TLR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Imiquimod (hydrochloride), Alternative-names: R 837 hydrochloride, CAS# 99011-78-6, Formula: C14H17ClN4, MWT: 276.7646, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Immunology/Inflammation, Target: Autophagy;Toll-like Receptor (TLR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Imiquimod (maleate), Alternative-names: R 837 maleate, CAS# 896106-16-4, Formula: C18H20N4O4, MWT: 356.3758, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Immunology/Inflammation, Target: Autophagy;Toll-like Receptor (TLR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Altretamine, Alternative-names: ENT-50852;RB-1515;WR-95704, CAS# 645-05-6, Formula: C9H18N6, MWT: 210.2794, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: DNA Alkylator/Crosslinker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Altretamine (hydrochloride), Alternative-names: ENT-50852 hydrochloride;RB-1515 hydrochloride;WR-95704 hydrochloride, CAS# 2975-00-0, Formula: C9H19ClN6, MWT: 246.7404, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: DNA Alkylator/Crosslinker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Budesonide, Alternative-names: , CAS# 51333-22-3, Formula: C25H34O6, MWT: 430.5339, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Carmofur, Alternative-names: HCFU, CAS# 61422-45-5, Formula: C11H16FN3O3, MWT: 257.2614, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Nucleoside Antimetabolite/Analog, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
Megestrol (Acetate), Alternative-names: , CAS# 595-33-5, Formula: C24H32O4, MWT: 384.5085, Solubility: DMSO: 11.53 mg/mL (Need ultrasonic)
, Clinical_Information: Launched, Pathway: Others;Autophagy, Target: Progesterone Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Pamidronate (Disodium), Alternative-names: CGP 23339A, CAS# 57248-88-1, Formula: C3H11NNa2O7P2 2+, MWT: 281.0479054, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Ellagic acid, Alternative-names: , CAS# 476-66-4, Formula: C14H6O8, MWT: 302.1926, Solubility: DMSO: 0.75 mg/mL (Need ultrasonic), Clinical_Information: Phase 2, Pathway: Stem Cell/Wnt;Cell Cycle/DNA Damage, Target: Casein Kinase;Casein Kinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Felbamate, Alternative-names: , CAS# 25451-15-4, Formula: C11H14N2O4, MWT: 238.2399, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Felbamate (hydrate), Alternative-names: , CAS# 1177501-39-1, Formula: C11H16N2O5, MWT: 256.2551, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Lidocaine, Alternative-names: Lignocaine, CAS# 137-58-6, Formula: C14H22N2O, MWT: 234.3373, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Biapenem, Alternative-names: Biapenern;CL 186-815;L 627;LJC 10627, CAS# 120410-24-4, Formula: C15H18N4O4S, MWT: 350.3928, Solubility: H<sub>2</sub>O: 20 mg/mL (Need ultrasonic), Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cefoselis (sulfate), Alternative-names: FK-037, CAS# 122841-12-7, Formula: C19H24N8O10S3, MWT: 620.6365, Solubility: DMSO: ≥ 6.4 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cefoselis, Alternative-names: , CAS# 122841-10-5, Formula: C19H22N8O6S2, MWT: 522.558, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cefoselis (hydrochloride), Alternative-names: , CAS# 911212-25-4, Formula: C19H23ClN8O6S2, MWT: 559.0189, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Doripenem, Alternative-names: S 4661, CAS# 148016-81-3, Formula: C15H24N4O6S2, MWT: 420.5043, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Doripenem (monohydrate), Alternative-names: S 4661 monohydrate, CAS# 364622-82-2, Formula: C15H26N4O7S2, MWT: 438.5195, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Lopinavir, Alternative-names: ABT-378, CAS# 192725-17-0, Formula: C37H48N4O5, MWT: 628.8008, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Anti-infection, Target: HIV Protease;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Mianserin, Alternative-names: Mianserine, CAS# 24219-97-4, Formula: C18H20N2, MWT: 264.3648, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mianserin (hydrochloride), Alternative-names: , CAS# 21535-47-7, Formula: C18H21ClN2, MWT: 300.8257, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Mosapride, Alternative-names: TAK-370;AS-4370, CAS# 112885-41-3, Formula: C21H25ClFN3O3, MWT: 421.8929, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Mosapride (citrate), Alternative-names: TAK-370 citrate;AS-4370 citrate, CAS# 112885-42-4, Formula: C27H33ClFN3O10, MWT: 614.0164, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Nafamostat, Alternative-names: , CAS# 81525-10-2, Formula: C19H17N5O2, MWT: 347.3706, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Ser/Thr Protease, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Nafamostat (mesylate), Alternative-names: FUT-175, CAS# 82956-11-4, Formula: C21H25N5O8S2, MWT: 539.5819, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Ser/Thr Protease, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Nafamostat (hydrochloride), Alternative-names: , CAS# 80251-32-7, Formula: C19H19Cl2N5O2, MWT: 420.2924, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Ser/Thr Protease, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Bimatoprost, Alternative-names: AGN 192024, CAS# 155206-00-1, Formula: C25H37NO4, MWT: 415.5656, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Alfuzosin, Alternative-names: SL 77499, CAS# 81403-80-7, Formula: C19H27N5O4, MWT: 389.4488, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Alfuzosin (hydrochloride), Alternative-names: SL 77499-10, CAS# 81403-68-1, Formula: C19H28ClN5O4, MWT: 425.9097, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Prazosin, Alternative-names: , CAS# 19216-56-9, Formula: C19H21N5O4, MWT: 383.4012, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Prazosin (hydrochloride), Alternative-names: , CAS# 19237-84-4, Formula: C19H22ClN5O4, MWT: 419.8621, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Autophagy, Target: Adrenergic Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Tizanidine, Alternative-names: , CAS# 51322-75-9, Formula: C9H8ClN5S, MWT: 253.7113, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tizanidine (hydrochloride), Alternative-names: , CAS# 64461-82-1, Formula: C9H9Cl2N5S, MWT: 290.1723, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tranilast, Alternative-names: MK 341;SB 252218, CAS# 53902-12-8, Formula: C18H17NO5, MWT: 327.3313, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tranilast (Sodium), Alternative-names: Sodium Tranilast;MK 341 Sodium;SB 252218 Sodium, CAS# 104931-56-8, Formula: C18H16NNaO5, MWT: 349.3131, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| BMS-538203, Alternative-names: , CAS# 543730-41-2, Formula: C12H12FNO5, MWT: 269.2258, Solubility: DMSO: ≥ 54 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease;Anti-infection, Target: HIV Integrase;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| IWP L6, Alternative-names: , CAS# 1427782-89-5, Formula: C25H20N4O2S2, MWT: 472.5819, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt, Target: Porcupine, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| SGC-CBP30, Alternative-names: , CAS# 1613695-14-9, Formula: C28H33ClN4O3, MWT: 509.0396, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Epigenetic Reader Domain, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| SB 242235, Alternative-names: , CAS# 193746-75-7, Formula: C19H20FN5O, MWT: 353.3934, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: p38 MAPK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| GlyH-101, Alternative-names: , CAS# 328541-79-3, Formula: C19H15Br2N3O3, MWT: 493.1487, Solubility: DMSO: ≥ 58 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: CFTR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Mutant EGFR inhibitor, Alternative-names: , CAS# 1421373-62-7, Formula: C27H30ClN7O2, MWT: 520.0258, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nav1.7 inhibitor, Alternative-names: , CAS# 1355631-24-1, Formula: C15H11Cl3FNO4S, MWT: 426.6745, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| GPR40 Activator 1, Alternative-names: , CAS# 1309435-60-6, Formula: C31H31NO3S, MWT: 497.6477, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: GPR40, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Mutant IDH1 inhibitor, Alternative-names: , CAS# 1429180-08-4, Formula: C25H34N6O3, MWT: 466.5759, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Isocitrate Dehydrogenase (IDH), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| GSK-3 inhibitor 1, Alternative-names: , CAS# 603272-51-1, Formula: C22H17ClFN5O2, MWT: 437.8541, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt;PI3K/Akt/mTOR, Target: GSK-3;GSK-3, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| SAR7334 (hydrochloride), Alternative-names: , CAS# 1333207-63-8, Formula: C21H24Cl3N3O, MWT: 440.79376, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Merimepodib, Alternative-names: VI-21497;VX-497;MMP, CAS# 198821-22-6, Formula: C23H24N4O6, MWT: 452.4599, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Phase 4, Pathway: Anti-infection;Cell Cycle/DNA Damage, Target: HBV;Nucleoside Antimetabolite/Analog, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Gossypol, Alternative-names: BL 193, CAS# 303-45-7, Formula: C30H30O8, MWT: 518.5544, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Apoptosis, Target: Bcl-2 Family, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Deracoxib, Alternative-names: SC 046;SC 46;SC 59046, CAS# 169590-41-4, Formula: C17H14F3N3O3S, MWT: 397.3716, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Brexpiprazole, Alternative-names: OPC-34712, CAS# 913611-97-9, Formula: C25H27N3O2S, MWT: 433.5658, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| CC0651, Alternative-names: , CAS# 1319207-44-7, Formula: C20H21Cl2NO6, MWT: 442.2898, Solubility: DMSO: ≥ 56 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: E1/E2/E3 Enzyme, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pitavastatin, Alternative-names: NK-104, CAS# 147511-69-1, Formula: C25H24FNO4, MWT: 421.4608, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: HMG-CoA Reductase (HMGCR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Rosuvastatin (Calcium), Alternative-names: Rosuvastatin hemicalcium;ZD 4522 Calcium, CAS# 147098-20-2, Formula: C22H27Ca0.5FN3O6S, MWT: 500.57, Solubility: DMSO: 100 mg/mL; Water <1 mg/mL, Clinical_Information: Launched, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;HMG-CoA Reductase (HMGCR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Rosuvastatin, Alternative-names: ZD 4522, CAS# 287714-41-4, Formula: C22H28FN3O6S, MWT: 481.5376, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: HMG-CoA Reductase (HMGCR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tarafenacin (D-tartrate), Alternative-names: SVT-40776 D-tartrate, CAS# 1159101-48-0, Formula: C25H26F4N2O8, MWT: 558.4761, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tarafenacin, Alternative-names: SVT-40776, CAS# 385367-47-5, Formula: C21H20F4N2O2, MWT: 408.3893, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| VRT752271, Alternative-names: Ulixertinib, CAS# 869886-67-9, Formula: C21H22Cl2N4O2, MWT: 433.331, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt;MAPK/ERK Pathway, Target: ERK;ERK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Losartan, Alternative-names: DuP-753, CAS# 114798-26-4, Formula: C22H23ClN6O, MWT: 422.9106, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Losartan (potassium), Alternative-names: DuP-753 potassium, CAS# 124750-99-8, Formula: C22H22ClKN6O, MWT: 461.00098, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| YLF-466D, Alternative-names: C24, CAS# 1273323-67-3, Formula: C29H20ClNO3, MWT: 465.927, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics;PI3K/Akt/mTOR, Target: AMPK;AMPK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AHU-377, Alternative-names: Sacubitril, CAS# 149709-62-6, Formula: C24H29NO5, MWT: 411.4908, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Metabolic Enzyme/Protease, Target: Neprilysin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| 25,26-Dihydroxyvitamin D3, Alternative-names: 25,26-Dihydroxycholecalciferol, CAS# 29261-12-9, Formula: C27H44O3, MWT: 416.6365, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Vitamin D Related, Target: VD/VDR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Imeglimin (hydrochloride), Alternative-names: EMD 387008 hydrochloride, CAS# 775351-61-6, Formula: C6H14ClN5, MWT: 191.6619, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Epigenetics;PI3K/Akt/mTOR, Target: AMPK;AMPK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| UNC0646, Alternative-names: , CAS# 1320288-17-2, Formula: C36H59N7O2, MWT: 621.8994, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Lenalidomide (hemihydrate), Alternative-names: CC-5013 hemihydrate, CAS# 847871-99-2, Formula: C13H14N3O3.5, MWT: 268.27, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Apoptosis, Target: TNF-alpha, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Xanomeline (oxalate), Alternative-names: LY246708, CAS# 141064-23-5, Formula: C16H25N3O5S, MWT: 371.4518, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Osthole, Alternative-names: NSC 31868;Osthol;Ostol, CAS# 484-12-8, Formula: C15H16O3, MWT: 244.2857, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| GSK 2830371, Alternative-names: , CAS# 1404456-53-6, Formula: C23H29ClN4O2S, MWT: 461.02, Solubility: DMSO: ≥ 51 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Phosphatase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Itraconazole, Alternative-names: R51211, CAS# 84625-61-6, Formula: C35H38Cl2N8O4, MWT: 705.6334, Solubility: DMSO: ≥ 7.3 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Fungal;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Silibinin, Alternative-names: Silybin;Silibinin A;Silymarin I, CAS# 22888-70-6, Formula: C25H22O10, MWT: 482.4362, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Venlafaxine, Alternative-names: Wy 45030, CAS# 93413-69-5, Formula: C17H27NO2, MWT: 277.4018, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Venlafaxine (hydrochloride), Alternative-names: Wy 45030 hydrochloride, CAS# 99300-78-4, Formula: C17H28ClNO2, MWT: 313.8627, Solubility: H<sub>2</sub>O: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Naratriptan, Alternative-names: GR-85548A, CAS# 121679-13-8, Formula: C17H25N3O2S, MWT: 335.4643, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Naratriptan (hydrochloride), Alternative-names: GR-85548A hydrochloride, CAS# 143388-64-1, Formula: C17H26ClN3O2S, MWT: 371.9252, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Fludarabine, Alternative-names: F-ara-A;NSC 118218, CAS# 21679-14-1, Formula: C10H12FN5O4, MWT: 285.2318, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Nucleoside Antimetabolite/Analog, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cefaclor, Alternative-names: , CAS# 53994-73-3, Formula: C15H14ClN3O4S, MWT: 367.8074, Solubility: DMSO: < 1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Mycophenolate mofetil, Alternative-names: RS 61443;TM-MMF, CAS# 128794-94-5, Formula: C23H31NO7, MWT: 433.4948, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Cephalexin, Alternative-names: Cefalexin;Cephacillin, CAS# 15686-71-2, Formula: C16H17N3O4S, MWT: 347.3889, Solubility: H<sub>2</sub>O: 10 mg/mL; DMSO: < 3.5 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Cephalexin (hydrochloride), Alternative-names: Cefalexin hydrochloride;Cephacillin hydrochloride, CAS# 59695-59-9, Formula: C16H18ClN3O4S, MWT: 383.8498, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Cephalexin (monohydrate), Alternative-names: Cefalexin hydrate;Cephacillin hydrate, CAS# 23325-78-2, Formula: C16H19N3O5S, MWT: 365.4042, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Irbesartan, Alternative-names: SR-47436;BMS-186295, CAS# 138402-11-6, Formula: C25H28N6O, MWT: 428.5294, Solubility: DMSO: ≥ 59 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nebivolol, Alternative-names: R 065824, CAS# 118457-14-0, Formula: C22H25F2NO4, MWT: 405.435, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Nebivolol (hydrochloride), Alternative-names: R 065824 hydrochloride, CAS# 152520-56-4, Formula: C22H26ClF2NO4, MWT: 441.8959, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pimobendan, Alternative-names: pimobendane, CAS# 74150-27-9, Formula: C19H18N4O2, MWT: 334.3718, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pimobendan (hydrochloride), Alternative-names: pimobendane hydrochloride, CAS# 77469-98-8, Formula: C19H19ClN4O2, MWT: 370.8328, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Sulfasalazine, Alternative-names: NSC 667219, CAS# 599-79-1, Formula: C18H14N4O5S, MWT: 398.3925, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;NF-κB, Target: Autophagy;NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Candesartan, Alternative-names: CV 11974, CAS# 139481-59-7, Formula: C24H20N6O3, MWT: 440.454, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Rizatriptan (benzoate), Alternative-names: MK 462, CAS# 145202-66-0, Formula: C22H25N5O2, MWT: 391.4662, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pyridostigmine (bromide), Alternative-names: , CAS# 101-26-8, Formula: C9H13BrN2O2, MWT: 261.1157, Solubility: H<sub>2</sub>O: 8.8 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Methimazole, Alternative-names: , CAS# 60-56-0, Formula: C4H6N2S, MWT: 114.16884, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Metolazone, Alternative-names: , CAS# 17560-51-9, Formula: C16H16ClN3O3S, MWT: 365.8345, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Thrombin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| QL47, Alternative-names: BTK Inhibitor, CAS# 1469988-75-7, Formula: C27H21N5O2, MWT: 447.4879, Solubility: DMSO: < 9.4 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Btk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| R788, Alternative-names: Fostamatinib, CAS# 901119-35-5, Formula: C23H26FN6O9P, MWT: 580.4595, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Protein Tyrosine Kinase/RTK, Target: Syk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Azilsartan (medoxomil monopotassium), Alternative-names: Azilsartan kamedoxomil;TAK 491 monopotassium, CAS# 863031-24-7, Formula: C30H23KN4O8, MWT: 606.6239, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Efavirenz, Alternative-names: DMP 266;EFV;L-743726, CAS# 154598-52-4, Formula: C14H9ClF3NO2, MWT: 315.675, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy;Anti-infection, Target: Reverse Transcriptase;Autophagy;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Cefoperazone, Alternative-names: , CAS# 62893-19-0, Formula: C25H27N9O8S2, MWT: 645.6674, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Riluzole, Alternative-names: PK 26124, CAS# 1744-22-5, Formula: C8H5F3N2OS, MWT: 234.1983, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfapyridine, Alternative-names: , CAS# 144-83-2, Formula: C11H11N3O2S, MWT: 249.2889, Solubility: DMSO: 1.02 mg/mL; H<sub>2</sub>O: < 1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Sulfameter, Alternative-names: Sulfametoxydiazine;5-Methoxysulfadiazine, CAS# 651-06-9, Formula: C11H12N4O3S, MWT: 280.303, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Prednisone, Alternative-names: Dehydrocortisone, CAS# 53-03-2, Formula: C21H26O5, MWT: 358.4281, Solubility: DMSO: ≥150 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Acetylcysteine, Alternative-names: N-Acetyl-L-cysteine;LNAC;NAC, CAS# 616-91-1, Formula: C5H9NO3S, MWT: 163.1949, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Ethynyl Estradiol, Alternative-names: 17α-Ethynylestradiol;Ethynylestradiol, CAS# 57-63-6, Formula: C20H24O2, MWT: 296.4034, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 4, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Naproxen (sodium), Alternative-names: , CAS# 26159-34-2, Formula: C14H13NaO3, MWT: 252.241, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;Autophagy, Target: COX;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Naproxen, Alternative-names: (S)-Naproxen, CAS# 22204-53-1, Formula: C14H14O3, MWT: 230.25916, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;Autophagy, Target: COX;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Nitazoxanide, Alternative-names: NTZ;NSC 697855, CAS# 55981-09-4, Formula: C12H9N3O5S, MWT: 307.28196, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Anti-infection, Target: Autophagy;Influenza Virus, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Orlistat, Alternative-names: Tetrahydrolipstatin;Ro-18-0647, CAS# 96829-58-2, Formula: C29H53NO5, MWT: 495.7348, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Fatty Acid Synthase (FAS), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Allopurinol, Alternative-names: , CAS# 315-30-0, Formula: C5H4N4O, MWT: 136.1115, Solubility: DMSO: 14 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Xanthine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Zafirlukast, Alternative-names: ICI 204219, CAS# 107753-78-6, Formula: C31H33N3O6S, MWT: 575.6752, Solubility: DMSO: ≥300 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Leukotriene Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Erythromycin, Alternative-names: , CAS# 114-07-8, Formula: C37H67NO13, MWT: 733.9268, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Amphotericin B, Alternative-names: , CAS# 1397-89-3, Formula: C47H73NO17, MWT: 924.079, Solubility: 10 mM in DMSO; H<sub>2</sub>O: < 0.1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Albendazole, Alternative-names: , CAS# 54965-21-8, Formula: C12H15N3O2S, MWT: 265.3314, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Chlorothiazide, Alternative-names: , CAS# 58-94-6, Formula: C7H6ClN3O4S2, MWT: 295.7232, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| L-(-)-α-Methyldopa, Alternative-names: MK-351;Methyldopa, CAS# 555-30-6, Formula: C10H13NO4, MWT: 211.21452, Solubility: DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| L-(-)-α-Methyldopa (hydrochloride), Alternative-names: MK-351 hydrochloride;Methyldopa hydrochloride, CAS# 884-39-9, Formula: C10H14ClNO4, MWT: 247.67546, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Nitrofurazone, Alternative-names: NFZ;Nitrofural, CAS# 59-87-0, Formula: C6H6N4O4, MWT: 198.13624, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Ketoprofen, Alternative-names: , CAS# 22071-15-4, Formula: C16H14O3, MWT: 254.28056, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Adenosine, Alternative-names: Adenine riboside;D-Adenosine, CAS# 58-61-7, Formula: C10H13N5O4, MWT: 267.2413, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Autophagy, Target: Nucleoside Antimetabolite/Analog;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Cytarabine, Alternative-names: Cytosine β-D-arabinofuranoside;Cytosine Arabinoside;Ara-C, CAS# 147-94-4, Formula: C9H13N3O5, MWT: 243.2166, Solubility: DMSO: 17.3 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Autophagy, Target: Nucleoside Antimetabolite/Analog;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Cytarabine (hydrochloride), Alternative-names: Cytosine β-D-arabinofuranoside hydrochloride;Cytosine Arabinoside hydrochloride;Ara-C hydrochloride, CAS# 69-74-9, Formula: C9H14ClN3O5, MWT: 279.6776, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Autophagy, Target: Nucleoside Antimetabolite/Analog;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Zolmitriptan, Alternative-names: BW-311C90;311C90, CAS# 139264-17-8, Formula: C16H21N3O2, MWT: 287.3568, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Phenylbutazone, Alternative-names: , CAS# 50-33-9, Formula: C19H20N2O2, MWT: 308.3743, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| USP7/USP47 inhibitor, Alternative-names: , CAS# 1247825-37-1, Formula: C18H11Cl2N3O3S3, MWT: 484.3992, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: Deubiquitinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| B-Raf inhibitor 1, Alternative-names: , CAS# 1093100-40-3, Formula: C26H19ClN8, MWT: 478.9357, Solubility: DMSO: ≥ 53 mg/mL, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: Raf, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| B-Raf inhibitor 1 (dihydrochloride), Alternative-names: , CAS# 1191385-19-9, Formula: C26H21Cl3N8, MWT: 551.8575, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: Raf, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Dapivirine, Alternative-names: TMC120;R147681, CAS# 244767-67-7, Formula: C20H19N5, MWT: 329.39836, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: Phase 3, Pathway: Anti-infection;Anti-infection, Target: Reverse Transcriptase;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| S1RA, Alternative-names: E-52862, CAS# 878141-96-9, Formula: C20H23N3O2, MWT: 337.4155, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Sigma Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| S1RA (hydrochloride), Alternative-names: E-52862 hydrochloride, CAS# 1265917-14-3, Formula: C20H24ClN3O2, MWT: 373.8765, Solubility: DMSO: ≥ 57 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Sigma Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| ZLN005, Alternative-names: , CAS# 49671-76-3, Formula: C17H18N2, MWT: 250.3382, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: PGC-1α, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| CPI-203, Alternative-names: , CAS# 1446144-04-2, Formula: C19H18ClN5OS, MWT: 399.8971, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Epigenetic Reader Domain, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| Adrafinil, Alternative-names: CRL 40028, CAS# 63547-13-7, Formula: C15H15NO3S, MWT: 289.3495, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Sunifiram, Alternative-names: DM-235, CAS# 314728-85-3, Formula: C14H18N2O2, MWT: 246.3049, Solubility: DMSO: ≥ 2.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| NMDA, Alternative-names: N-Methyl-D-aspartic acid, CAS# 6384-92-5, Formula: C5H9NO4, MWT: 147.1293, Solubility: DMSO: ≥15 mg/mL (Need ultrasonic and warming to 60℃), Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| sn-Glycero-3-phosphocholine, Alternative-names: Choline Alfoscerate;Alpha-GPC;L-α-GPC, CAS# 28319-77-9, Formula: C8H20NO6P, MWT: 257.2213, Solubility: H<sub>2</sub>O: ≥ 2.8 mg/mL; DMSO: < 2.9 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Coluracetam, Alternative-names: MKC-231, CAS# 135463-81-9, Formula: C19H23N3O3, MWT: 341.4042, Solubility: DMSO: ≥ 20 mg/mL; H<sub>2</sub>O: 0.4 mg/mL (Need ultrasonic and warming), Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| (R)-Oxiracetam, Alternative-names: (R)-(+)-Oxiracetam, CAS# 68252-28-8, Formula: C6H10N2O3, MWT: 158.1552, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| LY2606368, Alternative-names: Prexasertib, CAS# 1234015-52-1, Formula: C18H19N7O2, MWT: 365.38916, Solubility: DMSO: ≥ 60 mg/mL, Clinical_Information: Phase 2, Pathway: Cell Cycle/DNA Damage, Target: Checkpoint Kinase (Chk), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Enalaprilat (dihydrate), Alternative-names: , CAS# 84680-54-6, Formula: C18H28N2O7, MWT: 384.4241, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Autophagy, Target: Angiotensin-converting Enzyme (ACE);Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Dofetilide, Alternative-names: UK 68789, CAS# 115256-11-6, Formula: C19H27N3O5S2, MWT: 441.5648, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Isradipine, Alternative-names: PN 200-110, CAS# 75695-93-1, Formula: C19H21N3O5, MWT: 371.3871, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Estrone, Alternative-names: E1;Oestrone, CAS# 53-16-7, Formula: C18H22O2, MWT: 270.3661, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Trichlormethiazide, Alternative-names: , CAS# 133-67-5, Formula: C8H8Cl3N3O4S2, MWT: 380.6558, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| 6-Aminocaproic acid, Alternative-names: EACA;Epsilon-Amino-n-caproic Acid;6-Aminohexanoic acid, CAS# 60-32-2, Formula: C6H13NO2, MWT: 131.1729, Solubility: H<sub>2</sub>O: ≥ 10 mM, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Aminoglutethimide, Alternative-names: DL-Aminoglutethimide, CAS# 125-84-8, Formula: C13H16N2O2, MWT: 232.2783, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Aromatase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amorolfine (hydrochloride), Alternative-names: Ro 14-4767/002;Amorolfin, CAS# 78613-38-4, Formula: C21H36ClNO, MWT: 353.9696, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Chloramphenicol, Alternative-names: , CAS# 56-75-7, Formula: C11H12Cl2N2O5, MWT: 323.1294, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Flurbiprofen, Alternative-names: (¡À)-Flurbiprofe, CAS# 5104-49-4, Formula: C15H13FO2, MWT: 244.2609, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: PGE synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Disulfiram, Alternative-names: Tetraethylthiuram disulfide;TETD, CAS# 97-77-8, Formula: C10H20N2S4, MWT: 296.5392, Solubility: DMSO: ≥150 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Aldehyde Dehydrogenase (ALDH), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| UNC0224, Alternative-names: , CAS# 1197196-48-7, Formula: C26H43N7O2, MWT: 485.6653, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| UNC0321, Alternative-names: , CAS# 1238673-32-9, Formula: C27H45N7O3, MWT: 515.6913, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| UNC 0631, Alternative-names: , CAS# 1320288-19-4, Formula: C37H61N7O2, MWT: 635.926, Solubility: DMSO: < 4.7 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| UNC 669, Alternative-names: , CAS# 1314241-44-5, Formula: C15H20BrN3O, MWT: 338.2428, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Gadobutrol, Alternative-names: ZK 135079, CAS# 770691-21-9, Formula: C18H31GdN4O9, MWT: 604.7101, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| ML314, Alternative-names: , CAS# 1448895-09-7, Formula: C24H28N4O3, MWT: 420.5041, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Neurotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Meclofenoxate (hydrochloride), Alternative-names: , CAS# 3685-84-5, Formula: C12H17Cl2NO3, MWT: 294.1743, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel;Membrane Transporter/Ion Channel;Neuronal Signaling, Target: nAChR;nAChR;iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| NBI-74330, Alternative-names: , CAS# 855527-92-3, Formula: C32H27F4N5O3, MWT: 605.5821, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Immunology/Inflammation, Target: CXCR;CXCR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Levofloxacin, Alternative-names: (-)-Ofloxacin, CAS# 100986-85-4, Formula: C18H20FN3O4, MWT: 361.3675, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 5-Aminosalicylic acid, Alternative-names: Mesalamine;5-ASA;Mesalazine, CAS# 89-57-6, Formula: C7H7NO3, MWT: 153.1354, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: MAPK/ERK Pathway;MAPK/ERK Pathway, Target: p38 MAPK;JNK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Ipratropium (bromide), Alternative-names: Sch 1000, CAS# 22254-24-6, Formula: C20H30BrNO3, MWT: 412.3611, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfanilamide, Alternative-names: Sulphanilamide, CAS# 63-74-1, Formula: C6H8N2O2S, MWT: 172.2049, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50g |
| Meprednisone, Alternative-names: , CAS# 1247-42-3, Formula: C22H28O5, MWT: 372.4547, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Autophagy, Target: Glucocorticoid Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Praziquantel, Alternative-names: , CAS# 55268-74-1, Formula: C19H24N2O2, MWT: 312.4061, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Busulfan, Alternative-names: , CAS# 55-98-1, Formula: C6H14O6S2, MWT: 246.3018, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: DNA Alkylator/Crosslinker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Carbamazepine, Alternative-names: CBZ;NSC 169864, CAS# 298-46-4, Formula: C15H12N2O, MWT: 236.2686, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Membrane Transporter/Ion Channel, Target: Autophagy;Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hydrocortisone, Alternative-names: Cortisol, CAS# 50-23-7, Formula: C21H30O5, MWT: 362.4599, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Torsemide, Alternative-names: Torasemide, CAS# 56211-40-6, Formula: C16H20N4O3S, MWT: 348.42, Solubility: DMSO: ≥ 3.4 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Desonide, Alternative-names: , CAS# 638-94-8, Formula: C24H32O6, MWT: 416.5073, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Didanosine, Alternative-names: 2',3'-Dideoxyinosine;ddI, CAS# 69655-05-6, Formula: C10H12N4O3, MWT: 236.2273, Solubility: DMSO: ≥ 65 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Reverse Transcriptase;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Lamivudine, Alternative-names: , CAS# 134678-17-4, Formula: C8H11N3O3S, MWT: 229.2562, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Reverse Transcriptase;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Eplerenone, Alternative-names: Epoxymexrenone, CAS# 107724-20-9, Formula: C24H30O6, MWT: 414.4914, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Mineralocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Hydrochlorothiazide, Alternative-names: HCTZ, CAS# 58-93-5, Formula: C7H8ClN3O4S2, MWT: 297.7391, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Stem Cell/Wnt;TGF-beta/Smad, Target: TGF-beta/Smad;TGF-beta/Smad, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Piroxicam, Alternative-names: , CAS# 36322-90-4, Formula: C15H13N3O4S, MWT: 331.3464, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Bergapten, Alternative-names: 5-Methoxypsoralen, CAS# 484-20-8, Formula: C12H8O4, MWT: 216.1895, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;Cytochrome P450, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Pioglitazone (hydrochloride), Alternative-names: U 72107A;AD 4833, CAS# 112529-15-4, Formula: C19H21ClN2O3S, MWT: 392.8996, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;NF-κB, Target: PPAR;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| NVP-QAV-572, Alternative-names: , CAS# 957209-68-6, Formula: C17H19F2N7O3S2, MWT: 471.5047, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: PI3K/Akt/mTOR, Target: PI3K, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Oxonic acid (potassium salt), Alternative-names: Potassium azaorotate;Potassium otastat;Potassium oxonate, CAS# 2207-75-2, Formula: C4H2KN3O4, MWT: 195.1747, Solubility: H<sub>2</sub>O: ≥ 2 mg/mL; DMSO: < 1.9 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| AdipoRon, Alternative-names: , CAS# 924416-43-3, Formula: C27H28N2O3, MWT: 428.5228, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adiponectin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Glipizide, Alternative-names: CP 28720;K 4024, CAS# 29094-61-9, Formula: C21H27N5O4S, MWT: 445.5352, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Adefovir dipivoxil, Alternative-names: GS 0840, CAS# 142340-99-6, Formula: C20H32N5O8P, MWT: 501.4706, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: HBV;Reverse Transcriptase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Azathioprine, Alternative-names: BW 57-322, CAS# 446-86-6, Formula: C9H7N7O2S, MWT: 277.2626, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Indomethacin, Alternative-names: Indometacin, CAS# 53-86-1, Formula: C19H16ClNO4, MWT: 357.78764, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;Autophagy, Target: COX;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Levonorgestrel, Alternative-names: D-Norgestrel, CAS# 797-63-7, Formula: C21H28O2, MWT: 312.4458, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Progesterone Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
Gemfibrozil, Alternative-names: CI-719, CAS# 25812-30-0, Formula: C15H22O3, MWT: 250.3334, Solubility: DMSO: ≥ 34 mg/mL
, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;NF-κB, Target: PPAR;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Indapamide, Alternative-names: , CAS# 26807-65-8, Formula: C16H16ClN3O3S, MWT: 365.8345, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Methylprednisolone, Alternative-names: U 7532, CAS# 83-43-2, Formula: C22H30O5, MWT: 374.4706, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Autophagy, Target: Glucocorticoid Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Meloxicam, Alternative-names: , CAS# 71125-38-7, Formula: C14H13N3O4S2, MWT: 351.4007, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;Autophagy, Target: COX;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Methocarbamol, Alternative-names: , CAS# 532-03-6, Formula: C11H15NO5, MWT: 241.2405, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Prednisolone, Alternative-names: , CAS# 50-24-8, Formula: C21H28O5, MWT: 360.444, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Thiabendazole, Alternative-names: 2-(4-Thiazolyl)benzimidazole, CAS# 148-79-8, Formula: C10H7N3S, MWT: 201.2477, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Guaifenesin, Alternative-names: Guaiacol glyceryl ether;Guaiphenesin;Glycerol guaiacolate, CAS# 93-14-1, Formula: C10H14O4, MWT: 198.2158, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Nevirapine, Alternative-names: BI-RG 587;NSC 641530;NVP, CAS# 129618-40-2, Formula: C15H14N4O, MWT: 266.2979, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Reverse Transcriptase;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
Nimodipine, Alternative-names: BAY-e 9736, CAS# 66085-59-4, Formula: C21H26N2O7, MWT: 418.44034, Solubility:
DMSO: ≥85 mg/mL; Water: <1 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Autophagy, Target: Calcium Channel;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Gadodiamide (hydrate), Alternative-names: , CAS# 122795-43-1, Formula: C16H28GdN5O9, MWT: 591.6716, Solubility: DMSO: 16 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Oxybutynin, Alternative-names: , CAS# 5633-20-5, Formula: C22H31NO3, MWT: 357.4865, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Oxybutynin (chloride), Alternative-names: , CAS# 1508-65-2, Formula: C22H32ClNO3, MWT: 393.9474, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Enoxacin, Alternative-names: AT 2266;CI 919, CAS# 74011-58-8, Formula: C15H17FN4O3, MWT: 320.3189, Solubility: DMSO: <1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Rifapentine, Alternative-names: DL 473;Cyclopentylrifampicin, CAS# 61379-65-5, Formula: C47H64N4O12, MWT: 877.0306, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Suprofen, Alternative-names: , CAS# 40828-46-4, Formula: C14H12O3S, MWT: 260.30828, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: PGE synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pyrazinamide, Alternative-names: Pyrazinecarboxamide;Pyrazinoic acid amide, CAS# 98-96-4, Formula: C5H5N3O, MWT: 123.1127, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Rifampicin, Alternative-names: Rifampin;Rifamycin AMP, CAS# 13292-46-1, Formula: C43H58N4O12, MWT: 822.9402, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| β-Carotene, Alternative-names: Provitamin A;Carotaben;beta-Carotene;Lucarotin, CAS# 7235-40-7, Formula: C40H56, MWT: 536.8726, Solubility: DMSO, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Sulfadiazine, Alternative-names: , CAS# 68-35-9, Formula: C10H10N4O2S, MWT: 250.277, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Chlorprothixene, Alternative-names: , CAS# 113-59-7, Formula: C18H18ClNS, MWT: 315.8602, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Oxytetracycline, Alternative-names: , CAS# 79-57-2, Formula: C22H24N2O9, MWT: 460.434, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Ethionamide, Alternative-names: 2-ethylthioisonicotinamide, CAS# 536-33-4, Formula: C8H10N2S, MWT: 166.2434, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Vidarabine, Alternative-names: Ara-A;Arabinosyladenine;Adenine Arabinoside;9-β-D-Arabinofuranosyladenine, CAS# 5536-17-4, Formula: C10H13N5O4, MWT: 267.2413, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Anti-infection, Target: Nucleoside Antimetabolite/Analog;HSV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Bacitracin (Zinc), Alternative-names: Bacitracin zinc salt;Zinc bacitracin, CAS# 1405-89-6, Formula: C66H101N17O16SZn, MWT: 1486.057, Solubility: DMSO: < 1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Simvastatin, Alternative-names: MK 733, CAS# 79902-63-9, Formula: C25H38O5, MWT: 418.5662, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Metabolic Enzyme/Protease, Target: Autophagy;HMG-CoA Reductase (HMGCR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Ramipril, Alternative-names: , CAS# 87333-19-5, Formula: C23H32N2O5, MWT: 416.5106, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cysteine Protease inhibitor, Alternative-names: 2-Pyrimidinecarbonitrile, 4-[[4'-(aminomethyl)[1,1'-biphenyl]-3-yl]oxy]-, CAS# 921625-62-9, Formula: C18H14N4O, MWT: 302.33, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Proteasome, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| PLpro inhibitor, Alternative-names: , CAS# 1093070-14-4, Formula: C22H22N2O2, MWT: 346.4223, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: SARS-CoV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| ML-323, Alternative-names: , CAS# 1572414-83-5, Formula: C23H24N6, MWT: 384.4769, Solubility: DMSO: ≥ 49 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: Deubiquitinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PCI 29732, Alternative-names: , CAS# 330786-25-9, Formula: C22H21N5O, MWT: 371.435, Solubility: DMSO: ≥ 53 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Btk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| LEE011 (hydrochloride), Alternative-names: Ribociclib hydrochloride, CAS# 1211443-80-9, Formula: C23H31ClN8O, MWT: 470.9982, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: CDK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| LEE011 (succinate), Alternative-names: Ribociclib succinate, CAS# 1374639-75-4, Formula: C27H36N8O5, MWT: 552.6254, Solubility: DMSO: ≥ 19 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: CDK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| LEE011 (succinate hydrate), Alternative-names: Ribociclib succinate hydrate;LEE 011 succinate hydrate;LEE-011 succinate hydrate, CAS# 1374639-79-8, Formula: C27H38N8O6, MWT: 570.64, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: CDK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Angiotensin II human, Alternative-names: Angiotensin II;Hypertensin II;Ang II;DRVYIHPF, CAS# 4474-91-3, Formula: C50H71N13O12, MWT: 1046.179, Solubility: H<sub>2</sub>O: ≥ 50 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| GDC-0623, Alternative-names: , CAS# 1168091-68-6, Formula: C16H14FIN4O3, MWT: 456.2102, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 1, Pathway: MAPK/ERK Pathway, Target: MEK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| MK-4827 (hydrochloride), Alternative-names: Niraparib hydrochloride, CAS# 1038915-64-8, Formula: C19H21ClN4O, MWT: 356.8492, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: PARP;PARP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
MK-4827 (tosylate), Alternative-names: Niraparib tosylate, CAS# 1038915-73-9, Formula: C26H28N4O4S, MWT: 492.5899, Solubility: DMSO: ≥ 490 mg/mL
, Clinical_Information: Launched, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: PARP;PARP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| GLPG0634, Alternative-names: Filgotinib, CAS# 1206161-97-8, Formula: C21H23N5O3S, MWT: 425.504, Solubility: DMSO: 6.8 mg/mL, Clinical_Information: Phase 3, Pathway: Epigenetics;Stem Cell/Wnt;JAK/STAT Signaling, Target: JAK;JAK;JAK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 25mg |
| SDZ 220-581 (hydrochloride), Alternative-names: , CAS# 179411-93-9, Formula: C16H18Cl2NO5P, MWT: 406.197582, Solubility: DMSO: 5 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| S186, Alternative-names: , CAS# 97759-16-5, Formula: C5H13CaNNaO7P2+3, MWT: 324.1729, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| LGX818, Alternative-names: Encorafenib, CAS# 1269440-17-6, Formula: C22H27ClFN7O4S, MWT: 540.0107, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: MAPK/ERK Pathway, Target: Raf, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Chlorthalidone, Alternative-names: , CAS# 77-36-1, Formula: C14H11ClN2O4S, MWT: 338.7661, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Eprosartan (mesylate), Alternative-names: SKF-108566J, CAS# 144143-96-4, Formula: C24H28N2O7S2, MWT: 520.6183, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ranolazine, Alternative-names: CVT 303;RS 43285-003, CAS# 95635-55-5, Formula: C24H33N3O4, MWT: 427.5365, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Membrane Transporter/Ion Channel, Target: Calcium Channel;Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Ranitidine (hydrochloride), Alternative-names: , CAS# 66357-59-3, Formula: C13H23ClN4O3S, MWT: 350.8647, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
Acetylcholine (chloride), Alternative-names: Ach;ACh chloride, CAS# 60-31-1, Formula: C7H16ClNO2, MWT: 181.6604, Solubility: DMSO: ≥ 30 mg/mL
, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Autophagy, Target: Calcium Channel;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Acipimox, Alternative-names: K-9321, CAS# 51037-30-0, Formula: C6H6N2O3, MWT: 154.1234, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Nifedipine, Alternative-names: , CAS# 21829-25-4, Formula: C17H18N2O6, MWT: 346.33462, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Autophagy, Target: Calcium Channel;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Amiloride, Alternative-names: MK-870, CAS# 2609-46-3, Formula: C6H8ClN7O, MWT: 229.627, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amiloride (hydrochloride), Alternative-names: MK-870 hydrochloride, CAS# 2016-88-8, Formula: C6H9Cl2N7O, MWT: 266.088, Solubility: DMSO: ≥ 90 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Chlorpheniramine (maleate), Alternative-names: Chlorphenamine maleate, CAS# 113-92-8, Formula: C20H23ClN2O4, MWT: 390.8606, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Clofibrate, Alternative-names: , CAS# 637-07-0, Formula: C12H15ClO3, MWT: 242.6987, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;NF-κB, Target: PPAR;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Fenoprofen (Calcium), Alternative-names: , CAS# 34597-40-5, Formula: C15H14Ca0.5O3, MWT: 262.30886, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Erdosteine, Alternative-names: RV 144, CAS# 84611-23-4, Formula: C8H11NO4S2, MWT: 249.3072, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: NF-κB, Target: NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Proparacaine (Hydrochloride), Alternative-names: Proxymetacaine Hydrochloride, CAS# 5875-06-9, Formula: C16H27ClN2O3, MWT: 330.8502, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pranlukast, Alternative-names: ONO-1078, CAS# 103177-37-3, Formula: C27H23N5O4, MWT: 481.5026, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Leukotriene Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Oxfendazole, Alternative-names: , CAS# 53716-50-0, Formula: C15H13N3O3S, MWT: 315.347, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Atracurium (besylate), Alternative-names: BW-33A, CAS# 64228-81-5, Formula: C65H82N2O18S2, MWT: 1243.479, Solubility: DMSO: <1 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: nAChR;nAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Butoconazole (nitrate), Alternative-names: RS 35887, CAS# 64872-77-1, Formula: C19H18Cl3N3O3S, MWT: 474.7885, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Azithromycin, Alternative-names: CP 62993, CAS# 83905-01-5, Formula: C38H72N2O12, MWT: 748.9845, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| ID-8, Alternative-names: , CAS# 147591-46-6, Formula: C16H14N2O4, MWT: 298.29336, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: DYRK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Gossypol (acetic acid), Alternative-names: (±)-Gossypol-acetic aci, CAS# 12542-36-8, Formula: C32H34O10, MWT: 578.6064, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Apoptosis, Target: Bcl-2 Family, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| LX1606, Alternative-names: Telotristat ethyl, CAS# 1033805-22-9, Formula: C27H26ClF3N6O3, MWT: 574.9819, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease, Target: Tryptophan Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
GSK962040, Alternative-names: Camicinal, CAS# 923565-21-3, Formula: C25H33FN4O, MWT: 424.5541, Solubility: DMSO: 12.73 mg/mL (Need ultrasonic)
, Clinical_Information: Phase 2, Pathway: GPCR/G Protein, Target: Motilin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| GSK962040 (hydrochloride), Alternative-names: Camicinal hydrochloride;GSK 962040 hydrochloride;GSK-962040 hydrochloride, CAS# 923565-22-4, Formula: C25H34ClFN4O, MWT: 461.0151, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: GPCR/G Protein, Target: Motilin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Orotic acid, Alternative-names: 6-Carboxyuracil;Vitamin B13, CAS# 65-86-1, Formula: C5H4N2O4, MWT: 156.0963, Solubility: DMSO: 2 mg/mL; H<sub>2</sub>O: < 1 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Nucleoside Antimetabolite/Analog, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| L-Phenylalanine, Alternative-names: (S)-2-Amino-3-phenylpropionic acid, CAS# 63-91-2, Formula: C9H11NO2, MWT: 165.1891, Solubility: H<sub>2</sub>O: ≥ 46 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| JIB-04, Alternative-names: , CAS# 199596-05-9, Formula: C17H13ClN4, MWT: 308.7649, Solubility: DMSO: 22.5 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Demethylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| JSH-23, Alternative-names: , CAS# 749886-87-1, Formula: C16H20N2, MWT: 240.3434, Solubility: DMSO: ≥ 56 mg/mL, Clinical_Information: No Development Reported, Pathway: NF-κB, Target: NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| UNC2250, Alternative-names: , CAS# 1493694-70-4, Formula: C24H36N6O2, MWT: 440.5816, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: TAM Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| BAY 87-2243, Alternative-names: , CAS# 1227158-85-1, Formula: C26H26F3N7O2, MWT: 525.5256, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Flubendazole, Alternative-names: , CAS# 31430-15-6, Formula: C16H12FN3O3, MWT: 313.2832, Solubility: DMSO:1 mg/mL; H<sub>2</sub>O: <1 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tenovin 6 (Hydrochloride), Alternative-names: Tenovin 2, CAS# 1011301-29-3, Formula: C25H35ClN4O2S, MWT: 491.089, Solubility: DMSO: ≥ 49 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy;Epigenetics;Cell Cycle/DNA Damage;Apoptosis;Epigenetics;Cell Cycle/DNA Damage, Target: Autophagy;Sirtuin;Sirtuin;MDM-2/p53;HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| TRO 19622, Alternative-names: Olesoxime;NSC 21311, CAS# 22033-87-0, Formula: C27H45NO, MWT: 399.6523, Solubility: DMSO: ≥ 51 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Nedocromil, Alternative-names: FPL 59002, CAS# 69049-73-6, Formula: C19H17NO7, MWT: 371.3408, Solubility: DMSO: 15 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Leukotriene Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Chloroxine, Alternative-names: , CAS# 773-76-2, Formula: C9H5Cl2NO, MWT: 214.0481, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cimetidine, Alternative-names: SKF-92334, CAS# 51481-61-9, Formula: C10H16N6S, MWT: 252.3392, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| EPZ004777, Alternative-names: , CAS# 1338466-77-5, Formula: C28H41N7O4, MWT: 539.6696, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| EPZ004777 (hydrochloride), Alternative-names: , CAS# 1380316-03-9, Formula: C28H42ClN7O4, MWT: 576.1306, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pasireotide, Alternative-names: SOM 230;SOM 320, CAS# 396091-73-9, Formula: C58H66N10O9, MWT: 1047.206, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Somatostatin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| CW-069, Alternative-names: , CAS# 1594094-64-0, Formula: C23H21IN2O3, MWT: 500.3289, Solubility: DMSO: ≥ 52 mg/mL, Clinical_Information: No Development Reported, Pathway: Cytoskeleton;Cell Cycle/DNA Damage, Target: Kinesin;Kinesin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AP-III-a4, Alternative-names: ENOblock, CAS# 1177827-73-4, Formula: C31H43FN8O3, MWT: 594.7233, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Enolase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Clemastine (fumarate), Alternative-names: Meclastine fumarate, CAS# 14976-57-9, Formula: C25H30ClNO5, MWT: 459.9624, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein;Autophagy, Target: Histamine Receptor;Histamine Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Daidzein, Alternative-names: Isoflavone, CAS# 486-66-8, Formula: C15H10O4, MWT: 254.2375, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Cell Cycle/DNA Damage;NF-κB, Target: PPAR;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Oxibendazole, Alternative-names: , CAS# 20559-55-1, Formula: C12H15N3O3, MWT: 249.2658, Solubility: DMSO: 1 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Penicillamine, Alternative-names: D-(-)-Penicillamine, CAS# 52-67-5, Formula: C5H11NO2S, MWT: 149.2113, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Bifonazole, Alternative-names: , CAS# 60628-96-8, Formula: C22H18N2, MWT: 310.3917, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Metoprolol (Tartrate), Alternative-names: , CAS# 56392-17-7, Formula: C17H28NO6, MWT: 342.41, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Etidronic acid, Alternative-names: HEDPA;HEDP, CAS# 2809-21-4, Formula: C2H8O7P2, MWT: 206.0282, Solubility: H<sub>2</sub>O: ≥ 45 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Diethylstilbestrol, Alternative-names: DES;Stilbestrol, CAS# 56-53-1, Formula: C18H20O2, MWT: 268.3502, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Diltiazem (hydrochloride), Alternative-names: CRD-401, CAS# 33286-22-5, Formula: C22H27ClN2O4S, MWT: 450.9788, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Diphenhydramine (hydrochloride), Alternative-names: DPH, CAS# 147-24-0, Formula: C17H22ClNO, MWT: 291.8157, Solubility: DMSO: 18 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| Dapoxetine (hydrochloride), Alternative-names: LY-210448 hydrochloride, CAS# 129938-20-1, Formula: C21H24ClNO, MWT: 341.8744, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Roxatidine (Acetate Hydrochloride), Alternative-names: HOE 760, CAS# 93793-83-0, Formula: C19H29ClN2O4, MWT: 384.8976, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Prothionamide, Alternative-names: Protionamide, CAS# 14222-60-7, Formula: C9H12N2S, MWT: 180.27, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Idoxuridine, Alternative-names: 5-IUdR;IDU;IdUrd;5-Iodo-2′-deoxyuridine, CAS# 54-42-2, Formula: C9H11IN2O5, MWT: 354.0985, Solubility: DMSO: ≥ 65 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: HSV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Sparfloxacin, Alternative-names: , CAS# 110871-86-8, Formula: C19H22F2N4O3, MWT: 392.3998, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Felodipine, Alternative-names: , CAS# 72509-76-3, Formula: C18H19Cl2NO4, MWT: 384.2538, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Deflazacort, Alternative-names: , CAS# 14484-47-0, Formula: C25H31NO6, MWT: 441.51674, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Nizatidine, Alternative-names: , CAS# 76963-41-2, Formula: C12H21N5O2S2, MWT: 331.45744, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
Carbidopa, Alternative-names: (S)-(-)-Carbidopa, CAS# 28860-95-9, Formula: C10H14N2O4, MWT: 226.22916, Solubility:
DMSO: 4 mg/mL; Water: <1 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Dipyridamole, Alternative-names: , CAS# 58-32-2, Formula: C24H40N8O4, MWT: 504.6256, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Hydroxyurea, Alternative-names: Hydroxycarbamide, CAS# 127-07-1, Formula: CH4N2O2, MWT: 76.05466, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Autophagy, Target: DNA/RNA Synthesis;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Vitamin B12, Alternative-names: Cyanocobalamin, CAS# 68-19-9, Formula: C63H88CoN14O14P, MWT: 1355.365, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Diclofenac (Sodium), Alternative-names: , CAS# 15307-79-6, Formula: C14H10Cl2NNaO2, MWT: 318.1305, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Avobenzone, Alternative-names: , CAS# 70356-09-1, Formula: C20H22O3, MWT: 310.3869, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amlodipine, Alternative-names: , CAS# 88150-42-9, Formula: C20H25ClN2O5, MWT: 408.8759, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Metronidazole, Alternative-names: , CAS# 443-48-1, Formula: C6H9N3O3, MWT: 171.154, Solubility: DMSO 35 mg/mL; Water <1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Bacterial;Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Flutamide, Alternative-names: SCH 13521, CAS# 13311-84-7, Formula: C11H11F3N2O3, MWT: 276.2119, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Tioconazole, Alternative-names: , CAS# 65899-73-2, Formula: C16H13Cl3N2OS, MWT: 387.7112, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Cromolyn (sodium), Alternative-names: Disodium Cromoglycate, CAS# 15826-37-6, Formula: C23H14Na2O11, MWT: 512.3302, Solubility: H<sub>2</sub>O: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Tropicamide, Alternative-names: Ro 1-7683, CAS# 1508-75-4, Formula: C17H20N2O2, MWT: 284.3529, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfamethoxazole, Alternative-names: Ro 4-2130;STX 608, CAS# 723-46-6, Formula: C10H11N3O3S, MWT: 253.2776, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfisoxazole, Alternative-names: Sulfafurazole, CAS# 127-69-5, Formula: C11H13N3O3S, MWT: 267.3042, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Anti-infection, Target: Endothelin Receptor;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Crystal Violet, Alternative-names: Basic Violet 3;Gentian Violet;Hexamethylpararosaniline chloride;Methyl Violet 10B, CAS# 548-62-9, Formula: C25H30ClN3, MWT: 407.9788, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Phenindione, Alternative-names: Rectadione, CAS# 83-12-5, Formula: C15H10O2, MWT: 222.2387, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Alibendol, Alternative-names: , CAS# 26750-81-2, Formula: C13H17NO4, MWT: 251.2784, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Irsogladine, Alternative-names: Dicloguamine, CAS# 57381-26-7, Formula: C9H7Cl2N5, MWT: 256.0914, Solubility: DMSO：≥ 2.6 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Neuronal Signaling;GPCR/G Protein, Target: Phosphodiesterase (PDE);mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Irsogladine (maleate), Alternative-names: Dicloguamine maleate;MN1695, CAS# 84504-69-8, Formula: C13H11Cl2N5O4, MWT: 372.16354, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Neuronal Signaling;GPCR/G Protein, Target: Phosphodiesterase (PDE);mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Triamcinolone, Alternative-names: , CAS# 124-94-7, Formula: C21H27FO6, MWT: 394.4339, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 4, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Isoniazid, Alternative-names: INH;Isonicotinic acid hydrazide;Isonicotinic hydrazide;Isonicotinylhydrazine, CAS# 54-85-3, Formula: C6H7N3O, MWT: 137.1393, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Levamisole (hydrochloride), Alternative-names: (-)-Tetramisole hydrochloride, CAS# 16595-80-5, Formula: C11H13ClN2S, MWT: 240.7523, Solubility: DMSO: 15.5 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Enalapril (maleate), Alternative-names: , CAS# 76095-16-4, Formula: C24H32N2O9, MWT: 492.5189, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Menadione, Alternative-names: Vitamin K3, CAS# 58-27-5, Formula: C11H8O2, MWT: 172.18, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Sulfamethizole, Alternative-names: , CAS# 144-82-1, Formula: C9H10N4O2S2, MWT: 270.3313, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Sulbactam, Alternative-names: CP45899, CAS# 68373-14-8, Formula: C8H11NO5S, MWT: 233.2416, Solubility: DMSO: ≥ 70 mg/mL; H<sub>2</sub>O: 76.7 mg/mL (Need ultrasonic), Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tolfenamic Acid, Alternative-names: , CAS# 13710-19-5, Formula: C14H12ClNO2, MWT: 261.7036, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Pranoprofen, Alternative-names: , CAS# 52549-17-4, Formula: C15H13NO3, MWT: 255.26862, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: PGE synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfadimethoxine, Alternative-names: Sulphadimethoxine, CAS# 122-11-2, Formula: C12H14N4O4S, MWT: 310.3289, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Rimantadine, Alternative-names: 1-Rimantadine, CAS# 13392-28-4, Formula: C12H21N, MWT: 179.3018, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Influenza Virus, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Primidone, Alternative-names: , CAS# 125-33-7, Formula: C12H14N2O2, MWT: 218.2518, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nefiracetam, Alternative-names: DM9384;DZL-221, CAS# 77191-36-7, Formula: C14H18N2O2, MWT: 246.3049, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nicorandil, Alternative-names: , CAS# 65141-46-0, Formula: C8H9N3O4, MWT: 211.1748, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Meglumine, Alternative-names: Meglumin;Methylglucamin;Methylglucamine, CAS# 6284-40-8, Formula: C7H17NO5, MWT: 195.2136, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50g |
| Sarafloxacin (hydrochloride), Alternative-names: , CAS# 91296-87-6, Formula: C20H18ClF2N3O3, MWT: 421.825, Solubility: DMSO: 7.8 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Methscopolamine (bromide), Alternative-names: (-)-Scopolamine methyl bromide;Hyoscine methyl bromide, CAS# 155-41-9, Formula: C18H24BrNO4, MWT: 398.2915, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| ATP (disodium salt), Alternative-names: Disodium adenosine triphosphate;Adenosine 5'-triphosphate disodium salt, CAS# 987-65-5, Formula: C10H14N5Na2O13P3, MWT: 551.1447, Solubility: H<sub>2</sub>O: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: P2X Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Meclizine (dihydrochloride), Alternative-names: Meclozine dihydrochloride;NSC28728, CAS# 1104-22-9, Formula: C25H29Cl3N2, MWT: 463.8701, Solubility: DMSO: 1 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mometasone furoate, Alternative-names: Sch32088, CAS# 83919-23-7, Formula: C27H30Cl2O6, MWT: 521.4295, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Propylthiouracil, Alternative-names: 6-n-Propylthiouracil;6-Propyl-2-thiouracil;PTU, CAS# 51-52-5, Formula: C7H10N2OS, MWT: 170.2321, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lacidipine, Alternative-names: , CAS# 103890-78-4, Formula: C26H33NO6, MWT: 455.5433, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Procarbazine (Hydrochloride), Alternative-names: , CAS# 366-70-1, Formula: C12H20ClN3O, MWT: 257.7597, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: DNA Alkylator/Crosslinker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ondansetron, Alternative-names: GR38032, CAS# 99614-02-5, Formula: C18H19N3O, MWT: 293.3629, Solubility: DMSO:< 1 mg/mL;H<sub>2</sub>O:< 1 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Liranaftate, Alternative-names: Piritetrate;M-732, CAS# 88678-31-3, Formula: C18H20N2O2S, MWT: 328.4286, Solubility: DMSO: < 1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| D-Cycloserine, Alternative-names: , CAS# 68-41-7, Formula: C3H6N2O2, MWT: 102.0919, Solubility: DMSO: 1 mg/mL (Need warming), Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Raltegravir, Alternative-names: MK-0518, CAS# 518048-05-0, Formula: C20H21FN6O5, MWT: 444.4164, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Anti-infection, Target: HIV Integrase;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Taurine, Alternative-names: 2-Aminoethanesulfonic acid, CAS# 107-35-7, Formula: C2H7NO3S, MWT: 125.1469, Solubility: H<sub>2</sub>O: 24 mg/mL, Clinical_Information: Phase 4, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Mirtazapine, Alternative-names: Org3770;6-Azamianserin, CAS# 85650-52-8, Formula: C17H19N3, MWT: 265.3529, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Chlormezanone, Alternative-names: , CAS# 80-77-3, Formula: C11H12ClNO3S, MWT: 273.7359, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Urapidil (hydrochloride), Alternative-names: , CAS# 64887-14-5, Formula: C20H30ClN5O3, MWT: 423.9369, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;GPCR/G Protein, Target: Adrenergic Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| AV-412, Alternative-names: MP412, CAS# 451493-31-5, Formula: C41H44ClFN6O7S2, MWT: 851.4055, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: Phase 1, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AV-412 (free base), Alternative-names: MP-412 free base, CAS# 451492-95-8, Formula: C27H28ClFN6O, MWT: 507.0022, Solubility: DMSO：≥ 50 mg/mL, Clinical_Information: Phase 1, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| TAK-593, Alternative-names: , CAS# 1005780-62-0, Formula: C23H23N7O3, MWT: 445.4738, Solubility: DMSO: ≥ 48.5 mg/mL, Clinical_Information: Phase 1, Pathway: Protein Tyrosine Kinase/RTK;Protein Tyrosine Kinase/RTK, Target: VEGFR;PDGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Inauhzin, Alternative-names: INZ, CAS# 309271-94-1, Formula: C25H19N5OS2, MWT: 469.5813, Solubility: DMSO: 21 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage;Apoptosis, Target: Sirtuin;Sirtuin;MDM-2/p53, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| PSI-7976, Alternative-names: , CAS# 1190308-01-0, Formula: C22H29FN3O9P, MWT: 529.4525, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: HCV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Atglistatin, Alternative-names: , CAS# 1469924-27-3, Formula: C17H21N3O, MWT: 283.3681, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: ATGL, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| FLI-06, Alternative-names: , CAS# 313967-18-9, Formula: C25H30N2O5, MWT: 438.5161, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt, Target: Notch, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Telotristat, Alternative-names: LP-778902, CAS# 1033805-28-5, Formula: C25H22ClF3N6O3, MWT: 546.9288, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease, Target: Tryptophan Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ginkgolide A, Alternative-names: , CAS# 15291-75-5, Formula: C20H24O9, MWT: 408.3992, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ciprofloxacin, Alternative-names: , CAS# 85721-33-1, Formula: C17H18FN3O3, MWT: 331.3415, Solubility: DMSO: < 0.1 mg/mL; Acetic acid: ≥ 165 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Diclazuril, Alternative-names: , CAS# 101831-37-2, Formula: C17H9Cl3N4O2, MWT: 407.638, Solubility: DMSO: 17 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Flunarizine (dihydrochloride), Alternative-names: , CAS# 30484-77-6, Formula: C26H28Cl2F2N2, MWT: 477.4167, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| XCT790, Alternative-names: , CAS# 725247-18-7, Formula: C23H13F9N4O3S, MWT: 596.4249488, Solubility: DMSO: 21 mg/mL, Clinical_Information: No Development Reported, Pathway: Others;Autophagy, Target: Estrogen Receptor/ERR;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Walrycin B, Alternative-names: Walrycin-B, CAS# 878419-78-4, Formula: C14H10F3N5O2, MWT: 337.2567, Solubility: DMSO: 11.5 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Fenticonazole (Nitrate), Alternative-names: REC 15-1476, CAS# 73151-29-8, Formula: C24H21Cl2N3O4S, MWT: 518.4122, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Rebamipide, Alternative-names: OPC12759;Proamipide, CAS# 90098-04-7, Formula: C19H15ClN2O4, MWT: 370.7864, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Epalrestat, Alternative-names: ONO2235, CAS# 82159-09-9, Formula: C15H13NO3S2, MWT: 319.3986, Solubility: DMSO: ≥ 3.1 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Aldose Reductase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Aspartame, Alternative-names: , CAS# 22839-47-0, Formula: C14H18N2O5, MWT: 294.3031, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Phentolamine (mesylate), Alternative-names: Phentolamine methanesulfonate, CAS# 65-28-1, Formula: C18H23N3O4S, MWT: 377.4579, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nimesulide, Alternative-names: R805, CAS# 51803-78-2, Formula: C13H12N2O5S, MWT: 308.3098, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dyclonine (hydrochloride), Alternative-names: Dyclocaine hydrochloride, CAS# 536-43-6, Formula: C18H28ClNO2, MWT: 325.8734, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Memantine (hydrochloride), Alternative-names: , CAS# 41100-52-1, Formula: C12H22ClN, MWT: 215.7628, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Metabolic Enzyme/Protease;Membrane Transporter/Ion Channel;Neuronal Signaling, Target: Autophagy;Cytochrome P450;iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Cyproheptadine (hydrochloride), Alternative-names: , CAS# 969-33-5, Formula: C21H22ClN, MWT: 323.8591, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Lornoxicam, Alternative-names: Chlortenoxicam;Ro 13-9297;TS110, CAS# 70374-39-9, Formula: C13H10ClN3O4S2, MWT: 371.8192, Solubility: DMSO: 3.7 mg/mL (Need ultrasonic and warming), Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Captopril, Alternative-names: SA333, CAS# 62571-86-2, Formula: C9H15NO3S, MWT: 217.2853, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Orphenadrine (citrate), Alternative-names: , CAS# 4682-36-4, Formula: C24H31NO8, MWT: 461.5049, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tolnaftate, Alternative-names: , CAS# 2398-96-1, Formula: C19H17NOS, MWT: 307.4094, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Terazosin (hydrochloride dihydrate), Alternative-names: , CAS# 70024-40-7, Formula: C19H30ClN5O6, MWT: 459.9244, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Terazosin, Alternative-names: , CAS# 63590-64-7, Formula: C19H25N5O4, MWT: 387.4329, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bromhexine (hydrochloride), Alternative-names: , CAS# 611-75-6, Formula: C14H21Br2ClN2, MWT: 412.5909, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Tiopronin, Alternative-names: , CAS# 1953-02-2, Formula: C5H9NO3S, MWT: 163.1949, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ipragliflozin, Alternative-names: ASP1941, CAS# 761423-87-4, Formula: C21H21FO5S, MWT: 404.4518, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Membrane Transporter/Ion Channel, Target: SGLT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Go 6983, Alternative-names: Gö 6983;Goe 6983, CAS# 133053-19-7, Formula: C26H26N4O3, MWT: 442.5096, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: TGF-beta/Smad;Epigenetics, Target: PKC;PKC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dydrogesterone, Alternative-names: , CAS# 152-62-5, Formula: C21H28O2, MWT: 312.4458, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Progesterone Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Btk inhibitor 1 (R enantiomer), Alternative-names: , CAS# 1022150-12-4, Formula: C22H22N6O, MWT: 386.4497, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Btk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Btk inhibitor 1 (R enantiomer hydrochloride), Alternative-names: , CAS# 1553977-42-6, Formula: C22H23ClN6O, MWT: 422.9106, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Btk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| PCI-32765 (Racemate), Alternative-names: Ibrutinib Racemate, CAS# 936563-87-0, Formula: C25H24N6O2, MWT: 440.4971, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Protein Tyrosine Kinase/RTK, Target: Btk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Moxonidine, Alternative-names: BDF5895, CAS# 75438-57-2, Formula: C9H12ClN5O, MWT: 241.6775, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Imidazoline Receptor;Imidazoline Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Moxonidine (hydrochloride), Alternative-names: BDF5895 hydrochloride, CAS# 75536-04-8, Formula: C9H13Cl2N5O, MWT: 278.1384, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Imidazoline Receptor;Imidazoline Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Argatroban, Alternative-names: Argipidine, CAS# 74863-84-6, Formula: C23H36N6O5S, MWT: 508.6341, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Thrombin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Mecarbinate, Alternative-names: Dimecarbin;Dimecarbine;Dimekarbin, CAS# 15574-49-9, Formula: C13H15NO3, MWT: 233.2631, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: HCV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Lisinopril, Alternative-names: , CAS# 76547-98-3, Formula: C21H31N3O5, MWT: 405.4879, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Lisinopril (dihydrate), Alternative-names: , CAS# 83915-83-7, Formula: C21H35N3O7, MWT: 441.5185, Solubility: DMSO: < 4.4 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Famotidine, Alternative-names: , CAS# 76824-35-6, Formula: C8H15N7O2S3, MWT: 337.4454, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Moexipril (hydrochloride), Alternative-names: RS-10085, CAS# 82586-52-5, Formula: C27H35ClN2O7, MWT: 535.029, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cilazapril, Alternative-names: Ro 31-2848, CAS# 88768-40-5, Formula: C22H31N3O5, MWT: 417.4986, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cilazapril (monohydrate), Alternative-names: Ro 31-2848 monohydrate, CAS# 92077-78-6, Formula: C22H33N3O6, MWT: 435.5139, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Adiphenine (hydrochloride), Alternative-names: , CAS# 50-42-0, Formula: C20H26ClNO2, MWT: 347.8789, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: nAChR;nAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Trimebutine, Alternative-names: , CAS# 39133-31-8, Formula: C22H29NO5, MWT: 387.4694, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Opioid Receptor;Opioid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Dexmedetomidine (hydrochloride), Alternative-names: (+)-Medetomidine hydrochloride;(S)-Medetomidine hydrochloride, CAS# 145108-58-3, Formula: C13H17ClN2, MWT: 236.7405, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Autophagy, Target: Adrenergic Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Betaxolol, Alternative-names: , CAS# 63659-18-7, Formula: C18H29NO3, MWT: 307.4278, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Betaxolol (hydrochloride), Alternative-names: SL75212, CAS# 63659-19-8, Formula: C18H30ClNO3, MWT: 343.8887, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fosinopril (sodium), Alternative-names: SQ28555, CAS# 88889-14-9, Formula: C30H45NNaO7P, MWT: 585.6443, Solubility: H<sub>2</sub>O: ≥ 20 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Almotriptan (malate), Alternative-names: PNU180638, CAS# 181183-52-8, Formula: C21H31N3O7S, MWT: 469.5517, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Temocapril (hydrochloride), Alternative-names: , CAS# 110221-44-8, Formula: C23H29ClN2O5S2, MWT: 513.0698, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Gabexate (mesylate), Alternative-names: FOY, CAS# 56974-61-9, Formula: C17H27N3O7S, MWT: 417.4772, Solubility: H<sub>2</sub>O: ≥ 250 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Metabolic Enzyme/Protease, Target: Proteasome;Factor Xa, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Rasagiline (mesylate), Alternative-names: AGN1135;TVP1012, CAS# 161735-79-1, Formula: C13H17NO3S, MWT: 267.34398, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Neuronal Signaling, Target: Autophagy;Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Azasetron (hydrochloride), Alternative-names: Y-25130 hydrochloride, CAS# 123040-16-4, Formula: C17H21Cl2N3O3, MWT: 386.2729, Solubility: H<sub>2</sub>O:≥ 3.9 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Flunixin (meglumine), Alternative-names: , CAS# 42461-84-7, Formula: C21H28F3N3O7, MWT: 491.4581, Solubility: H<sub>2</sub>O: ≥ 44 mg/mL, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| CCT007093, Alternative-names: , CAS# 176957-55-4, Formula: C15H12OS2, MWT: 272.3852, Solubility: DMSO: ≥ 2.7 mg/mL; DMSO: < 5.1 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Mdivi-1, Alternative-names: Mitochondrial division inhibitor 1, CAS# 338967-87-6, Formula: C15H10Cl2N2O2S, MWT: 353.2231, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Cytoskeleton, Target: Dynamin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| TMP269, Alternative-names: , CAS# 1314890-29-3, Formula: C25H21F3N4O3S, MWT: 514.5195, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: HDAC;HDAC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Siramesine (hydrochloride), Alternative-names: Lu 28-179 hydrochloride, CAS# 224177-60-0, Formula: C30H32ClFN2O, MWT: 491.0393, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Sigma Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Omadacycline (tosylate), Alternative-names: PTK 0796 tosylate;Amadacycline tosylate, CAS# 1075240-43-5, Formula: C36H48N4O10S, MWT: 728.8521, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Levoleucovorin (Calcium), Alternative-names: Calcium levofolinate;CL307782, CAS# 80433-71-2, Formula: C20H21CaN7O7, MWT: 511.50144, Solubility: H<sub>2</sub>O: ≥ 10 mM; H<sub>2</sub>O: < 9.2 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Antifolate, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Calcium N5-methyltetrahydrofolate, Alternative-names: NSC173328, CAS# 26560-38-3, Formula: C20H23CaN7O6, MWT: 497.5179, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: Antifolate, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Droxidopa, Alternative-names: L-DOPS;DOPS;SM5688, CAS# 23651-95-8, Formula: C9H11NO5, MWT: 213.1873, Solubility: DMSO: 1.8 mg/mL (Need ultrasonic and warming), Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Blonanserin, Alternative-names: AD-5423, CAS# 132810-10-7, Formula: C23H30FN3, MWT: 367.5028, Solubility: DMSO: < 3.7 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cisatracurium (besylate), Alternative-names: , CAS# 96946-42-8, Formula: C65H82N2O18S2, MWT: 1243.479, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel;Autophagy, Target: nAChR;nAChR;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ibutilide (fumarate), Alternative-names: U70226E, CAS# 122647-32-9, Formula: C22H38N2O5S, MWT: 442.61, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Probucol, Alternative-names: , CAS# 23288-49-5, Formula: C31H48O2S2, MWT: 516.8416, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Dextrose, Alternative-names: D-Glucose;Grape sugar;Glucopyranose, CAS# 50-99-7, Formula: C6H12O6, MWT: 180.1559, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| AR 231453, Alternative-names: , CAS# 733750-99-7, Formula: C21H24FN7O5S, MWT: 505.5225632, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: GPR119, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Mestranol, Alternative-names: , CAS# 72-33-3, Formula: C21H26O2, MWT: 310.4299, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Naftopidil, Alternative-names: KT-611;BM-15275, CAS# 57149-07-2, Formula: C24H28N2O3, MWT: 392.4907, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| (S)-(+)-Rolipram, Alternative-names: (+)-Rolipram;(S)-Rolipram, CAS# 85416-73-5, Formula: C16H21NO3, MWT: 275.3428, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Fudosteine, Alternative-names: , CAS# 13189-98-5, Formula: C6H13NO3S, MWT: 179.2373, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Atropine (sulfate monohydrate), Alternative-names: Atropine sulfate hydrate, CAS# 5908-99-6, Formula: C17H25NO7S, MWT: 387.4479, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein;Autophagy, Target: mAChR;mAChR;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Betrixaban, Alternative-names: PRT054021, CAS# 330942-05-7, Formula: C23H22ClN5O3, MWT: 451.9055, Solubility: DMSO: 22 mg/mL, Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease, Target: Factor Xa, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dorsomorphin (dihydrochloride), Alternative-names: BML-275 dihydrochloride;Compound C dihydrochloride, CAS# 1219168-18-9, Formula: C24H27Cl2N5O, MWT: 472.4101, Solubility: H<sub>2</sub>O: ≥ 48 mg/mL; DMSO: 5.2 mg/mL (Need ultrasonic), Clinical_Information: Phase 1, Pathway: Autophagy;Epigenetics;PI3K/Akt/mTOR, Target: Autophagy;AMPK;AMPK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| MG 149, Alternative-names: , CAS# 1243583-85-8, Formula: C22H28O3, MWT: 340.4559, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: Histone Acetyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Almorexant, Alternative-names: ACT 078573, CAS# 871224-64-5, Formula: C29H31F3N2O3, MWT: 512.5632496, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: GPCR/G Protein, Target: Orexin Receptor (OX Receptor), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Almorexant (hydrochloride), Alternative-names: ACT-078573 hydrochloride, CAS# 913358-93-7, Formula: C29H32ClF3N2O3, MWT: 549.0241896, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: Phase 3, Pathway: GPCR/G Protein, Target: Orexin Receptor (OX Receptor), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| AMG 925, Alternative-names: , CAS# 1401033-86-0, Formula: C26H29N7O2, MWT: 471.5542, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;Protein Tyrosine Kinase/RTK, Target: CDK;FLT3, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dorsomorphin, Alternative-names: BML-275;Compound C, CAS# 866405-64-3, Formula: C24H25N5O, MWT: 399.4882, Solubility: 10 mM in DMSO, Clinical_Information: Phase 1, Pathway: Autophagy;Epigenetics;PI3K/Akt/mTOR, Target: Autophagy;AMPK;AMPK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Sitafloxacin, Alternative-names: DU6859a, CAS# 127254-12-0, Formula: C19H18ClF2N3O3, MWT: 409.8143, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Sitafloxacin (hydrate), Alternative-names: DU6859a hydrate, CAS# 163253-35-8, Formula: C19H18ClF2N3O3, MWT: 409.8143, Solubility: DMSO: < 9 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tebipenem pivoxil, Alternative-names: L084, CAS# 161715-24-8, Formula: C22H31N3O6S2, MWT: 497.6281, Solubility: DMSO: ≥150 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Dichlorphenamide, Alternative-names: Diclofenamide, CAS# 120-97-8, Formula: C6H6Cl2N2O4S2, MWT: 305.1588, Solubility: DMSO: ≥ 28 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Carbonic Anhydrase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Artemether, Alternative-names: Dihydroqinghaosu methyl ether;Dihydroartemisinin methyl ether;SM224, CAS# 71963-77-4, Formula: C16H26O5, MWT: 298.3746, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
Nalidixic acid, Alternative-names: , CAS# 389-08-2, Formula: C12H12N2O3, MWT: 232.2353, Solubility: DMSO: 6 mg/mL (Need ultrasonic)
, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| D-Mannitol, Alternative-names: Mannitol;Mannite, CAS# 69-65-8, Formula: C6H14O6, MWT: 182.1718, Solubility: H<sub>2</sub>O: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| L-Carnitine, Alternative-names: Levocarnitine, CAS# 541-15-1, Formula: C7H15NO3, MWT: 161.1989, Solubility: 10 mM in DMSO; 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| D-Sorbitol, Alternative-names: Glucitol;D-Glucitol;Sorbitol, CAS# 50-70-4, Formula: C6H14O6, MWT: 182.1718, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Paeoniflorin, Alternative-names: Peoniflorin, CAS# 23180-57-6, Formula: C23H28O11, MWT: 480.4618, Solubility: DMSO: ≥ 27 mg/mL, Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease, Target: HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| BTB06584, Alternative-names: , CAS# 219793-45-0, Formula: C19H12ClNO6S, MWT: 417.8197, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: ATP Synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Geniposidic acid, Alternative-names: , CAS# 27741-01-1, Formula: C16H22O10, MWT: 374.3399, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Tolbutamide, Alternative-names: , CAS# 64-77-7, Formula: C12H18N2O3S, MWT: 270.3479, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Launched, Pathway: Autophagy;Membrane Transporter/Ion Channel, Target: Autophagy;Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Levosimendan, Alternative-names: OR1259, CAS# 141505-33-1, Formula: C14H12N6O, MWT: 280.2847, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amantadine (hydrochloride), Alternative-names: 1-Adamantanamine hydrochloride;1-Adamantylamine hydrochloride;1-Aminoadamantane hydrochloride, CAS# 665-66-7, Formula: C10H18ClN, MWT: 187.7096, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Influenza Virus, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Bupropion (hydrochloride), Alternative-names: Amfebutamone hydrochloride, CAS# 31677-93-7, Formula: C13H19Cl2NO, MWT: 276.2021, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Dopamine Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Benserazide (hydrochloride), Alternative-names: Serazide;Ro 4-4602, CAS# 14919-77-8, Formula: C10H16ClN3O5, MWT: 293.7041, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Bupivacaine (hydrochloride), Alternative-names: , CAS# 18010-40-7, Formula: C18H29ClN2O, MWT: 324.8887, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: MAPK/ERK Pathway, Target: Ribosomal S6 Kinase (RSK), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Bethanechol (chloride), Alternative-names: Carbamyl-β-methylcholine chloride, CAS# 590-63-6, Formula: C7H17ClN2O2, MWT: 196.6751, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Chlorpromazine (hydrochloride), Alternative-names: , CAS# 69-09-0, Formula: C17H20Cl2N2S, MWT: 355.3251, Solubility: DMSO: ≥ 60 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;Autophagy;Neuronal Signaling;GPCR/G Protein;Membrane Transporter/Ion Channel;Membrane Transporter/Ion Channel, Target: Dopamine Receptor;Dopamine Receptor;Autophagy;5-HT Receptor;5-HT Receptor;Potassium Channel;Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Clindamycin (hydrochloride), Alternative-names: , CAS# 21462-39-5, Formula: C18H34Cl2N2O5S, MWT: 461.444, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Clonidine (hydrochloride), Alternative-names: , CAS# 4205-91-8, Formula: C9H10Cl3N3, MWT: 266.5548, Solubility: DMSO: 7.6 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pramipexole, Alternative-names: , CAS# 104632-26-0, Formula: C10H17N3S, MWT: 211.3271, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Domperidone, Alternative-names: R33812, CAS# 57808-66-9, Formula: C22H24ClN5O2, MWT: 425.9113, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| DMOG, Alternative-names: Dimethyloxallyl Glycine, CAS# 89464-63-1, Formula: C6H9NO5, MWT: 175.1394, Solubility: DMSO: 10 mM, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| AHU-377 (hemicalcium salt), Alternative-names: Sacubitril hemicalcium salt, CAS# 1369773-39-6, Formula: C24H29Ca0.5NO5+, MWT: 431.52921142, Solubility: DMSO: ≥ 54 mg/mL, Clinical_Information: Phase 4, Pathway: Metabolic Enzyme/Protease, Target: Neprilysin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| MMAF, Alternative-names: Monomethylauristatin F, CAS# 745017-94-1, Formula: C39H65N5O8, MWT: 731.9621, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;Cytoskeleton;Antibody-drug Conjugate/ADC Related, Target: Microtubule/Tubulin;Microtubule/Tubulin;ADC Cytotoxin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Estriol, Alternative-names: Oestriol, CAS# 50-27-1, Formula: C18H24O3, MWT: 288.3813, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fenbendazole, Alternative-names: , CAS# 43210-67-9, Formula: C15H13N3O2S, MWT: 299.3476, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fleroxacin, Alternative-names: AM-833, CAS# 79660-72-3, Formula: C17H18F3N3O3, MWT: 369.3383, Solubility: DMSO: < 1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Fluocinolone (Acetonide), Alternative-names: , CAS# 67-73-2, Formula: C24H30F2O6, MWT: 452.4882, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Gallamine Triethiodide, Alternative-names: , CAS# 65-29-2, Formula: C30H60I3N3O3, MWT: 891.5291, Solubility: H<sub>2</sub>O: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Lincomycin (hydrochloride), Alternative-names: U10149A, CAS# 859-18-7, Formula: C18H35ClN2O6S, MWT: 442.9983, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Loperamide (hydrochloride), Alternative-names: , CAS# 34552-83-5, Formula: C29H34Cl2N2O2, MWT: 513.4985, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;Autophagy, Target: Opioid Receptor;Opioid Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Manidipine, Alternative-names: , CAS# 89226-50-6, Formula: C35H38N4O6, MWT: 610.6994, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mitoxantrone, Alternative-names: mitozantrone, CAS# 65271-80-9, Formula: C22H28N4O6, MWT: 444.4809, Solubility: DMSO: ≥150 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Topoisomerase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Mitoxantrone (dihydrochloride), Alternative-names: mitozantrone dihydrochloride, CAS# 70476-82-3, Formula: C22H30Cl2N4O6, MWT: 517.4028, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Topoisomerase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Moroxydine (hydrochloride), Alternative-names: ABOB hydrochloride, CAS# 3160-91-6, Formula: C6H14ClN5O, MWT: 207.6613, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Influenza Virus, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mycophenolic acid, Alternative-names: Mycophenolate, CAS# 24280-93-1, Formula: C17H20O6, MWT: 320.3371, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nateglinide, Alternative-names: A4166;Senaglinide, CAS# 105816-04-4, Formula: C19H27NO3, MWT: 317.4226, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Neostigmine (Bromide), Alternative-names: Eustigmin bromide;Neoserine bromide, CAS# 114-80-7, Formula: C12H19BrN2O2, MWT: 303.1955, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Nitrendipine, Alternative-names: BAY-E-5009, CAS# 39562-70-4, Formula: C18H20N2O6, MWT: 360.3612, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Novobiocin (Sodium), Alternative-names: Albamycin;Cathomycin, CAS# 1476-53-5, Formula: C31H35N2NaO11, MWT: 634.6061, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Olopatadine (hydrochloride), Alternative-names: ALO4943A;KW4679, CAS# 140462-76-6, Formula: C21H24ClNO3, MWT: 373.8732, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ozagrel, Alternative-names: OKY-046, CAS# 82571-53-7, Formula: C13H12N2O2, MWT: 228.2466, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Factor Xa, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pancuronium (dibromide), Alternative-names: , CAS# 15500-66-0, Formula: C35H60Br2N2O4, MWT: 732.6699, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: nAChR;nAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| D-Pantothenic acid, Alternative-names: pantothenate;vitamin B5, CAS# 79-83-4, Formula: C9H17NO5, MWT: 219.23498, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Phenoxybenzamine (hydrochloride), Alternative-names: , CAS# 63-92-3, Formula: C18H23Cl2NO, MWT: 340.2873, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Propafenone (hydrochloride), Alternative-names: , CAS# 34183-22-7, Formula: C21H28ClNO3, MWT: 377.9049, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Quinine (hydrochloride dihydrate), Alternative-names: , CAS# 6119-47-7, Formula: C20H29ClN2O4, MWT: 396.9083, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Ribavirin, Alternative-names: , CAS# 36791-04-5, Formula: C8H12N4O5, MWT: 244.2047, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: RSV;HCV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Roxithromycin, Alternative-names: , CAS# 80214-83-1, Formula: C41H76N2O15, MWT: 837.0466, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Salbutamol (hemisulfate), Alternative-names: , CAS# 51022-70-9, Formula: C13H22NO5S0.5, MWT: 288.14, Solubility: H<sub>2</sub>O: 68 mg/mL; DMSO: <1 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Autophagy, Target: Adrenergic Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sotalol (hydrochloride), Alternative-names: , CAS# 959-24-0, Formula: C12H21ClN2O3S, MWT: 308.8247, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Spectinomycin (dihydrochloride), Alternative-names: , CAS# 21736-83-4, Formula: C14H26Cl2N2O7, MWT: 405.2715, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Sulfadoxine, Alternative-names: Sulphadoxine, CAS# 2447-57-6, Formula: C12H14N4O4S, MWT: 310.3289, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Tenoxicam, Alternative-names: , CAS# 59804-37-4, Formula: C13H11N3O4S2, MWT: 337.3741, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Tobramycin, Alternative-names: Nebramycin Factor 6;Deoxykanamycin B, CAS# 32986-56-4, Formula: C18H37N5O9, MWT: 467.5145, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Vardenafil, Alternative-names: , CAS# 224785-90-4, Formula: C23H32N6O4S, MWT: 488.603, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Xylazine, Alternative-names: BAY 1470, CAS# 7361-61-7, Formula: C12H16N2S, MWT: 220.3338, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Xylazine (hydrochloride), Alternative-names: BAY 1470 hydrochloride, CAS# 23076-35-9, Formula: C12H17ClN2S, MWT: 256.7948, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| CK-636, Alternative-names: CK-0944636, CAS# 442632-72-6, Formula: C16H16N2OS, MWT: 284.376, Solubility: DMSO: ≥ 49 mg/mL, Clinical_Information: No Development Reported, Pathway: Cytoskeleton, Target: Arp2/3 Complex, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| APY29, Alternative-names: , CAS# 1216665-49-4, Formula: C17H16N8, MWT: 332.3625, Solubility: DMSO: 10 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: IRE1, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Maprotiline (hydrochloride), Alternative-names: , CAS# 10347-81-6, Formula: C20H24ClN, MWT: 313.8643, Solubility: DMSO: ≥ 37 mg/mL, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| NAD+, Alternative-names: β-DPN;β-NAD;Coenzyme 1;Cozymase;DPN;Diphosphopyridine nucleotide;NAD;Nadide;β-Nicotinamide Adenine Dinucleotide, CAS# 53-84-9, Formula: C21H27N7O14P2, MWT: 663.4251, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Naphazoline (hydrochloride), Alternative-names: , CAS# 550-99-2, Formula: C14H15ClN2, MWT: 246.7353, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| DL-Epinephrine, Alternative-names: (±)-Epinephrine;(±)-Adrenaline;DL-Adrenali, CAS# 329-65-7, Formula: C9H13NO3, MWT: 183.2044, Solubility: DMSO: ≥ 1.8 mg/mL; DMSO: < 7.4 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| L-Epinephrine (Bitartrate), Alternative-names: (-)-Epinephrine (+)-bitartrate salt;L-Adrenaline (+)-bitartrate salt, CAS# 51-42-3, Formula: C13H19NO9, MWT: 333.2913, Solubility: DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| L-Epinephrine, Alternative-names: (-)-Epinephrine;L-Adrenaline;(-)-Adrenalin, CAS# 51-43-4, Formula: C9H13NO3, MWT: 183.2044, Solubility: DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Phenytoin, Alternative-names: 5,5-Diphenylhydantoin, CAS# 57-41-0, Formula: C15H12N2O2, MWT: 252.268, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Methacycline (hydrochloride), Alternative-names: , CAS# 3963-95-9, Formula: C22H23ClN2O8, MWT: 478.8796, Solubility: DMSO: 10 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Ciclopirox, Alternative-names: HOE296b, CAS# 29342-05-0, Formula: C12H17NO2, MWT: 207.2689, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Fungal;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dopamine (hydrochloride), Alternative-names: ASL279, CAS# 62-31-7, Formula: C8H12ClNO2, MWT: 189.6394, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ritodrine (hydrochloride), Alternative-names: DU21220, CAS# 23239-51-2, Formula: C17H22ClNO3, MWT: 323.8145, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Econazole (nitrate), Alternative-names: , CAS# 24169-02-6, Formula: C18H16Cl3N3O4, MWT: 444.69634, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Miconazole, Alternative-names: R18134, CAS# 22916-47-8, Formula: C18H14Cl4N2O, MWT: 416.1286, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Lomefloxacin (hydrochloride), Alternative-names: , CAS# 98079-52-8, Formula: C17H20ClF2N3O3, MWT: 387.8088, Solubility: H<sub>2</sub>O: 10 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Riboflavin, Alternative-names: Vitamin B2;E101, CAS# 83-88-5, Formula: C17H20N4O6, MWT: 376.3639, Solubility: DMSO: < 1 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Clomipramine (hydrochloride), Alternative-names: , CAS# 17321-77-6, Formula: C19H24Cl2N2, MWT: 351.3133, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cefprozil (monohydrate), Alternative-names: , CAS# 121123-17-9, Formula: C18H21N3O6S, MWT: 407.4408, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Scopine, Alternative-names: 6,7-Epoxytropine, CAS# 498-45-3, Formula: C8H13NO2, MWT: 155.1943, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tiotropium (bromide hydrate), Alternative-names: , CAS# 139404-48-1, Formula: C19H24BrNO5S2, MWT: 490.4315, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Trospium (chloride), Alternative-names: , CAS# 10405-02-4, Formula: C25H30ClNO3, MWT: 427.9636, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Azelastine (hydrochloride), Alternative-names: , CAS# 79307-93-0, Formula: C22H25Cl2N3O, MWT: 418.3594, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Prucalopride, Alternative-names: , CAS# 179474-81-8, Formula: C18H26ClN3O3, MWT: 367.8703, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| 5-Aminolevulinic acid (hydrochloride), Alternative-names: ALA;5-ALA, CAS# 5451-09-2, Formula: C5H10ClNO3, MWT: 167.5908, Solubility: DMSO: ≥ 150 mg/mL, Clinical_Information: Phase 4, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Clarithromycin, Alternative-names: , CAS# 81103-11-9, Formula: C38H69NO13, MWT: 747.9534, Solubility: DMSO: ≥ 7.4 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy;Metabolic Enzyme/Protease, Target: Bacterial;Autophagy;Cytochrome P450, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Clomiphene (citrate), Alternative-names: Clomifene citrate, CAS# 50-41-9, Formula: C32H36ClNO8, MWT: 598.0831, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Hydralazine (hydrochloride), Alternative-names: , CAS# 304-20-1, Formula: C8H9ClN4, MWT: 196.6369, Solubility: H<sub>2</sub>O: ≥ 2.3 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: HIF/HIF Prolyl-Hydroxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Oxacillin (sodium monohydrate), Alternative-names: Sodium oxacillin monohydrate, CAS# 7240-38-2, Formula: C19H20N3NaO6S, MWT: 441.4334, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Cloxacillin (sodium monohydrate), Alternative-names: , CAS# 7081-44-9, Formula: C19H19ClN3NaO6S, MWT: 475.8784, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amoxicillin (sodium), Alternative-names: , CAS# 34642-77-8, Formula: C16H19N3NaO5S+, MWT: 388.3933807, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Isoprenaline (hydrochloride), Alternative-names: Isoproterenol hydrochloride, CAS# 51-30-9, Formula: C11H18ClNO3, MWT: 247.7185, Solubility: DMSO: 14.5 mg/mL, Clinical_Information: Phase 3, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Medroxyprogesterone (acetate), Alternative-names: Medroxyprogesterone 17-acetate;MPA, CAS# 71-58-9, Formula: C24H34O4, MWT: 386.5244, Solubility: DMSO: 7 mg/mL; H<sub>2</sub>O: < 0.1 mg/mL, Clinical_Information: Phase 4, Pathway: Others, Target: Progesterone Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Neomycin (sulfate), Alternative-names: , CAS# 1405-10-3, Formula: C23H52N6O25S3, MWT: 908.88, Solubility: H<sub>2</sub>O: ≥ 31 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Anti-infection, Target: Calcium Channel;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| (R)-(-)-Phenylephrine (hydrochloride), Alternative-names: Phenylephrine hydrochloride, CAS# 61-76-7, Formula: C9H14ClNO2, MWT: 203.666, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Streptomycin (sulfate), Alternative-names: , CAS# 3810-74-0, Formula: C21H42N7O18S1.5, MWT: 728.69, Solubility: H<sub>2</sub>O: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Tetracaine (hydrochloride), Alternative-names: Amethocaine hydrochloride, CAS# 136-47-0, Formula: C15H25ClN2O2, MWT: 300.8242, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tetracycline (hydrochloride), Alternative-names: , CAS# 64-75-5, Formula: C22H25ClN2O8, MWT: 480.8955, Solubility: DMSO: 10 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Xylometazoline (hydrochloride), Alternative-names: , CAS# 1218-35-5, Formula: C16H25ClN2, MWT: 280.8361, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Phenacetin, Alternative-names: Acetophenetidin, CAS# 62-44-2, Formula: C10H13NO2, MWT: 179.2157, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Quinapril (hydrochloride), Alternative-names: , CAS# 82586-55-8, Formula: C25H31ClN2O5, MWT: 474.9771, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Trazodone (hydrochloride), Alternative-names: , CAS# 25332-39-2, Formula: C19H23Cl2N5O, MWT: 408.3248, Solubility: DMSO: ≥ 4.1 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Thiamphenicol, Alternative-names: Thiophenicol;Dextrosulphenidol, CAS# 15318-45-3, Formula: C12H15Cl2NO5S, MWT: 356.2222, Solubility: DMSO: ≥ 3.6 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Clobetasol propionate, Alternative-names: , CAS# 25122-46-7, Formula: C25H32ClFO5, MWT: 466.97, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Brompheniramine (maleate), Alternative-names: , CAS# 980-71-2, Formula: C20H23BrN2O4, MWT: 435.3116, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Miglitol, Alternative-names: BAY1099;BAY-m1099, CAS# 72432-03-2, Formula: C8H17NO5, MWT: 207.2243, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Acemetacin, Alternative-names: , CAS# 53164-05-9, Formula: C21H18ClNO6, MWT: 415.8237, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Tioxolone, Alternative-names: , CAS# 4991-65-5, Formula: C7H4O3S, MWT: 168.1699, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Carbonic Anhydrase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Idebenone, Alternative-names: , CAS# 58186-27-9, Formula: C19H30O5, MWT: 338.4385, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Buflomedil (hydrochloride), Alternative-names: , CAS# 35543-24-9, Formula: C17H26ClNO4, MWT: 343.8456, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Fluocinonide, Alternative-names: , CAS# 356-12-7, Formula: C26H32F2O7, MWT: 494.5249, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lonidamine, Alternative-names: DICA;Diclondazolic Acid;AF1890, CAS# 50264-69-2, Formula: C15H10Cl2N2O2, MWT: 321.1581, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Metabolic Enzyme/Protease, Target: Hexokinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ethisterone, Alternative-names: Pregneninolone;17α-Ethynyltestosterone, CAS# 434-03-7, Formula: C21H28O2, MWT: 312.4458, Solubility: DMSO: < 1 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Clorsulon, Alternative-names: L631529;MK401, CAS# 60200-06-8, Formula: C8H8Cl3N3O4S2, MWT: 380.6558, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Arecoline (hydrobromide), Alternative-names: Arecoline bromide, CAS# 300-08-3, Formula: C8H14BrNO2, MWT: 236.1063, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Norepinephrine (bitartrate monohydrate), Alternative-names: Noradrenaline bitartrate monohydrate, CAS# 108341-18-0, Formula: C12H19NO10, MWT: 337.28, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Autophagy, Target: Adrenergic Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Norepinephrine (hydrochloride), Alternative-names: Noradrenaline hydrochloride, CAS# 329-56-6, Formula: C8H12ClNO3, MWT: 205.6388, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Autophagy, Target: Adrenergic Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Nilvadipine, Alternative-names: FK235;FR34235, CAS# 75530-68-6, Formula: C19H19N3O6, MWT: 385.37066, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hygromycin B, Alternative-names: Hygrovetine, CAS# 31282-04-9, Formula: C20H37N3O13, MWT: 527.5201, Solubility: H<sub>2</sub>O: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection;Anti-infection, Target: Fungal;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Carbazochrome (sodium sulfonate), Alternative-names: , CAS# 51460-26-5, Formula: C10H11N4NaO5S, MWT: 322.2729, Solubility: DMSO: ≥ 49 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Amyloid-β, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Paroxetine (hydrochloride), Alternative-names: BRL29060 hydrochloride;BRL29060A, CAS# 78246-49-8, Formula: C19H21ClFNO3, MWT: 365.8264, Solubility: DMSO: ≥ 250 mg/mL; H<sub>2</sub>O: 2.12 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Autophagy, Target: Serotonin Transporter;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Amoxicillin, Alternative-names: Amoxycillin, CAS# 26787-78-0, Formula: C16H19N3O5S, MWT: 365.4042, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Amoxicillin (trihydrate), Alternative-names: Amoxycillin trihydrate, CAS# 61336-70-7, Formula: C16H25N3O8S, MWT: 419.45, Solubility: DMSO; H<sub>2</sub>O: 1.25 mg/mL (Need ultrasonic and warming), Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Niflumic acid, Alternative-names: , CAS# 4394-00-7, Formula: C13H9F3N2O2, MWT: 282.218, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Chloride Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bufexamac, Alternative-names: Bufexamic acid, CAS# 2438-72-4, Formula: C12H17NO3, MWT: 223.2683, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lamotrigine, Alternative-names: LTG;BW430C, CAS# 84057-84-1, Formula: C9H7Cl2N5, MWT: 256.0914, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Membrane Transporter/Ion Channel, Target: Autophagy;Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| PMSF, Alternative-names: Phenylmethylsulfonyl fluoride;Benzylsulfonyl fluoride, CAS# 329-98-6, Formula: C7H7FO2S, MWT: 174.1927, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Proteasome, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Niclosamide, Alternative-names: BAY2353, CAS# 50-65-7, Formula: C13H8Cl2N2O4, MWT: 327.1196, Solubility: DMSO: < 1 mg/mL, Clinical_Information: Launched, Pathway: JAK/STAT Signaling;Stem Cell/Wnt, Target: STAT;STAT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Niclosamide (monohydrate), Alternative-names: BAY2353 monohydrate, CAS# 73360-56-2, Formula: C13H10Cl2N2O5, MWT: 345.1349, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: JAK/STAT Signaling;Stem Cell/Wnt, Target: STAT;STAT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Bindarit, Alternative-names: AF2838, CAS# 130641-38-2, Formula: C19H20N2O3, MWT: 324.3737, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cinepazide (Maleate), Alternative-names: , CAS# 26328-04-1, Formula: C26H35N3O9, MWT: 533.5708, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cinepazide, Alternative-names: , CAS# 23887-46-9, Formula: C22H31N3O5, MWT: 417.49864, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Balicatib, Alternative-names: AAE581, CAS# 354813-19-7, Formula: C23H33N5O2, MWT: 411.54042, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: Phase 2, Pathway: Metabolic Enzyme/Protease, Target: Cathepsin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Verbascoside, Alternative-names: Acteoside;Kusaginin;TJC160, CAS# 61276-17-3, Formula: C29H36O15, MWT: 624.5872, Solubility: DMSO: ≥ 6.3 mg/mL, Clinical_Information: No Development Reported, Pathway: TGF-beta/Smad;Epigenetics, Target: PKC;PKC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Isoacteoside, Alternative-names: Isoverbascoside, CAS# 61303-13-7, Formula: C29H36O15, MWT: 624.5872, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Poliumoside, Alternative-names: , CAS# 94079-81-9, Formula: C35H46O19, MWT: 770.7283, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Moclobemide, Alternative-names: Ro111163, CAS# 71320-77-9, Formula: C13H17ClN2O2, MWT: 268.7393, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Pergolide (mesylate), Alternative-names: Pergolide methanesulfonate;LY127809, CAS# 66104-23-2, Formula: C20H30N2O3S2, MWT: 410.5938, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Ethambutol, Alternative-names: Emb, CAS# 74-55-5, Formula: C10H24N2O2, MWT: 204.3098, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Ethambutol (dihydrochloride), Alternative-names: Emb dihydrochloride, CAS# 1070-11-7, Formula: C10H26Cl2N2O2, MWT: 277.2316, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Doxycycline (hydrochloride), Alternative-names: , CAS# 10592-13-9, Formula: C22H25ClN2O8, MWT: 480.8955, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: MMP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Clinafloxacin, Alternative-names: PD 127391, CAS# 105956-97-6, Formula: C17H17ClFN3O3, MWT: 365.7866, Solubility: DMSO: < 1 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Pentamidine, Alternative-names: MP-601205, CAS# 100-33-4, Formula: C19H24N4O2, MWT: 340.4195, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pentamidine (dihydrochloride), Alternative-names: MP601205 dihydrochloride, CAS# 50357-45-4, Formula: C19H26Cl2N4O2, MWT: 413.3413, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Pemirolast (potassium), Alternative-names: TWT-8152;BMY 26517, CAS# 100299-08-9, Formula: C10H7KN6O, MWT: 266.3005, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Acebutolol (hydrochloride), Alternative-names: , CAS# 34381-68-5, Formula: C18H29ClN2O4, MWT: 372.8869, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ampiroxicam, Alternative-names: CP 65703, CAS# 99464-64-9, Formula: C20H21N3O7S, MWT: 447.4616, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Desloratadine, Alternative-names: Sch34117, CAS# 100643-71-8, Formula: C19H19ClN2, MWT: 310.8206, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| L-Hyoscyamine, Alternative-names: Daturine, CAS# 101-31-5, Formula: C17H23NO3, MWT: 289.3694, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cyclamic acid, Alternative-names: Cyclohexylsulfamic acid;Cyclamate, CAS# 100-88-9, Formula: C6H13NO3S, MWT: 179.2373, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Ouabain (Octahydrate), Alternative-names: Acocantherine;G-Strophanthin, CAS# 11018-89-6, Formula: C29H60O20, MWT: 728.77, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Autophagy, Target: Na+/K+ ATPase;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Allylthiourea, Alternative-names: Thiosinamine;N-Allylthiourea, CAS# 109-57-9, Formula: C4H8N2S, MWT: 116.1847, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Avanafil, Alternative-names: TA1790, CAS# 330784-47-9, Formula: C23H26ClN7O3, MWT: 483.9507, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
Sodium Picosulfate, Alternative-names: Sodium Picosulphate, CAS# 10040-45-6, Formula: C18H13NNa2O8S2, MWT: 481.4073, Solubility: DMSO: 14.44 mg/mL (Need ultrasonic)
, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
Probenecid, Alternative-names: , CAS# 57-66-9, Formula: C13H19NO4S, MWT: 285.3593, Solubility:
DMSO: ≥57 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Procaine, Alternative-names: , CAS# 59-46-1, Formula: C13H20N2O2, MWT: 236.3101, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Procaine (hydrochloride), Alternative-names: , CAS# 51-05-8, Formula: C13H21ClN2O2, MWT: 272.771, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Homatropine (Bromide), Alternative-names: Homatropine hydrobromide, CAS# 51-56-9, Formula: C16H22BrNO3, MWT: 356.2548, Solubility: DMSO: 21.5 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Hydroxyzine, Alternative-names: , CAS# 68-88-2, Formula: C21H27ClN2O2, MWT: 374.9043, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Hydroxyzine (dihydrochloride), Alternative-names: , CAS# 2192-20-3, Formula: C21H29Cl3N2O2, MWT: 447.8262, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Flavoxate (hydrochloride), Alternative-names: Rec-7-0040;DW61, CAS# 3717-88-2, Formula: C24H26ClNO4, MWT: 427.9205, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bismuth Subsalicylate, Alternative-names: Bismuth oxysalicylate;Bismuth(III) salicylate basic, CAS# 14882-18-9, Formula: C7H5BiO4, MWT: 362.0926, Solubility: DMSO: < 3.8 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: PGE synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Doxapram, Alternative-names: , CAS# 309-29-5, Formula: C24H30N2O2, MWT: 378.5072, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Doxapram (hydrochloride hydrate), Alternative-names: , CAS# 7081-53-0, Formula: C24H33ClN2O3, MWT: 432.9834, Solubility: DMSO: ≥ 55 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dibucaine, Alternative-names: Cinchocaine, CAS# 85-79-0, Formula: C20H29N3O2, MWT: 343.4632, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Dibucaine (hydrochloride), Alternative-names: Cinchocaine hydrochloride, CAS# 61-12-1, Formula: C20H30ClN3O2, MWT: 379.9241, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Methazolamide, Alternative-names: L584601, CAS# 554-57-4, Formula: C5H8N4O3S2, MWT: 236.272, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Carbonic Anhydrase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| (R)-(-)-Modafinic acid, Alternative-names: Armodafinic acid, CAS# 112111-45-2, Formula: C15H14O3S, MWT: 274.3349, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| (S)-(+)-Modafinic acid, Alternative-names: , CAS# 112111-44-1, Formula: C15H14O3S, MWT: 274.3349, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Solifenacin (hydrochloride), Alternative-names: YM905 hydrochloride, CAS# 180468-39-7, Formula: C23H27ClN2O2, MWT: 398.9257, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| AMG 487, Alternative-names: , CAS# 473719-41-4, Formula: C32H28F3N5O4, MWT: 603.591, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Immunology/Inflammation, Target: CXCR;CXCR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| PF-562271 (besylate), Alternative-names: PF562271 besylate;PF 562271 besylate, CAS# 939791-38-5, Formula: C27H26F3N7O6S2, MWT: 665.6639, Solubility: DMSO: 21.4 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK;Protein Tyrosine Kinase/RTK, Target: Pyk2;FAK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Norethindrone, Alternative-names: Norethisterone, CAS# 68-22-4, Formula: C20H26O2, MWT: 298.4193, Solubility: DMSO, Clinical_Information: Launched, Pathway: Others, Target: Progesterone Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Nafcillin (sodium monohydrate), Alternative-names: , CAS# 7177-50-6, Formula: C21H23N2NaO6S, MWT: 454.4719, Solubility: H<sub>2</sub>O: 19 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Tetrahydrozoline (hydrochloride), Alternative-names: Tetryzoline hydrochloride, CAS# 522-48-5, Formula: C13H17ClN2, MWT: 236.7405, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Bisacodyl, Alternative-names: , CAS# 603-50-9, Formula: C22H19NO4, MWT: 361.3906, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Carbimazole, Alternative-names: , CAS# 22232-54-8, Formula: C7H10N2O2S, MWT: 186.2315, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Nabumetone, Alternative-names: BRL14777, CAS# 42924-53-8, Formula: C15H16O2, MWT: 228.2863, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Spironolactone, Alternative-names: SC9420, CAS# 52-01-7, Formula: C24H32O4S, MWT: 416.5735, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others;Autophagy, Target: Androgen Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Ropivacaine (hydrochloride monohydrate), Alternative-names: , CAS# 132112-35-7, Formula: C17H29ClN2O2, MWT: 328.8773, Solubility: H<sub>2</sub>O: 14 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Nitroprusside (Sodium), Alternative-names: Ro 21-2498, CAS# 14402-89-2, Formula: C5FeN6Na2O, MWT: 261.9176, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ronidazole, Alternative-names: , CAS# 7681-76-7, Formula: C6H8N4O4, MWT: 200.1521, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Guanabenz (Acetate), Alternative-names: Wy8678 acetate, CAS# 23256-50-0, Formula: C10H12Cl2N4O2, MWT: 291.1339, Solubility: DMSO: ≥ 51 mg/ml, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Dequalinium (Chloride), Alternative-names: , CAS# 522-51-0, Formula: C30H40Cl2N4, MWT: 527.5714, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Hexamethonium (Bromide), Alternative-names: , CAS# 55-97-0, Formula: C12H30Br2N2, MWT: 362.188, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: nAChR;nAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Decamethonium (Bromide), Alternative-names: , CAS# 541-22-0, Formula: C16H38Br2N2, MWT: 418.2943, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: nAChR;nAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Zinc Pyrithione, Alternative-names: , CAS# 13463-41-7, Formula: C10H8N2O2S2Zn+2, MWT: 317.6916, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: Proton Pump, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Propranolol (hydrochloride), Alternative-names: , CAS# 318-98-9, Formula: C16H22ClNO2, MWT: 295.8044, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Autophagy, Target: Adrenergic Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Mefenamic acid, Alternative-names: , CAS# 61-68-7, Formula: C15H15NO2, MWT: 241.2851, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Triamterene, Alternative-names: , CAS# 396-01-0, Formula: C12H11N7, MWT: 253.2626, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sulfacetamide (Sodium), Alternative-names: , CAS# 127-56-0, Formula: C8H9N2NaO3S, MWT: 236.2234, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| CEP-37440, Alternative-names: , CAS# 1391712-60-9, Formula: C30H38ClN7O3, MWT: 580.1208, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Phase 1, Pathway: Protein Tyrosine Kinase/RTK;Protein Tyrosine Kinase/RTK, Target: ALK;FAK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| BQ-788 (sodium salt), Alternative-names: , CAS# 156161-89-6, Formula: C34H50N5NaO7, MWT: 663.7798, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Phase 1, Pathway: GPCR/G Protein, Target: Endothelin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| MI-773, Alternative-names: , CAS# 1303607-07-9, Formula: C29H34Cl2FN3O3, MWT: 562.503, Solubility: DMSO: ≥ 53 mg/mL, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: MDM-2/p53, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| ACT-132577, Alternative-names: aprocitentan, CAS# 1103522-45-7, Formula: C16H14Br2N6O4S, MWT: 546.1932, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: Phase 1, Pathway: GPCR/G Protein, Target: Endothelin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| R788 (disodium hexahydrate), Alternative-names: Fostamatinib disodium hexahydrate, CAS# 914295-16-2, Formula: C23H24FN6Na2O9P.6H2O, MWT: 732.51, Solubility: DMSO: 31.81 mg/mL (Need ultrasonic); H<sub>2</sub>O: 6.6 mg/mL (Need ultrasonic and warming); H<sub>2</sub>O: < 6.8 mg/mL, Clinical_Information: Phase 3, Pathway: Protein Tyrosine Kinase/RTK, Target: Syk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| b-AP15, Alternative-names: NSC 687852, CAS# 1009817-63-3, Formula: C22H17N3O6, MWT: 419.38688, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: Deubiquitinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| TCS JNK 5a, Alternative-names: JNK Inhibitor IX, CAS# 312917-14-9, Formula: C20H16N2OS, MWT: 332.4189, Solubility: DMSO: ≥ 51 mg/mL, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: JNK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pimecrolimus, Alternative-names: SDZ-ASM 981, CAS# 137071-32-0, Formula: C43H68ClNO11, MWT: 810.4531, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Otilonium (bromide), Alternative-names: Octylonium bromide;SP63, CAS# 26095-59-0, Formula: C29H43BrN2O4, MWT: 563.5667, Solubility: DMSO: 110 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Alverine (citrate), Alternative-names: NSC 35459, CAS# 5560-59-8, Formula: C26H35NO7, MWT: 473.5586, Solubility: DMSO: 22 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Danofloxacin (mesylate), Alternative-names: CP 76136-27, CAS# 119478-55-6, Formula: C20H24FN3O6S, MWT: 453.4845, Solubility: DMSO: 4.5 mg/mL (Need ultrasonic and warming), Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Meisoindigo, Alternative-names: Dian III;N-Methylisoindigotin;Natura-α, CAS# 97207-47-1, Formula: C17H12N2O2, MWT: 276.2894, Solubility: DMSO: ≥ 51 mg/mL, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: Apoptosis, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Kif15-IN-1, Alternative-names: , CAS# 672926-32-8, Formula: C20H22N4O5S, MWT: 430.4775, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cytoskeleton;Cell Cycle/DNA Damage, Target: Kinesin;Kinesin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Kif15-IN-2, Alternative-names: , CAS# 672926-33-9, Formula: C20H20N6O4S, MWT: 440.4756, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cytoskeleton;Cell Cycle/DNA Damage, Target: Kinesin;Kinesin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Enrofloxacin, Alternative-names: BAY-Vp2674;PD160788, CAS# 93106-60-6, Formula: C19H22FN3O3, MWT: 359.3947, Solubility: DMSO: 1 mg/mL; H<sub>2</sub>O: < 1 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Medetomidine (hydrochloride), Alternative-names: MPV785, CAS# 86347-15-1, Formula: C13H17ClN2, MWT: 236.7405, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Diclofenac (diethylamine), Alternative-names: , CAS# 78213-16-8, Formula: C18H22Cl2N2O2, MWT: 369.2855, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Atovaquone, Alternative-names: Atavaquone, CAS# 95233-18-4, Formula: C22H19ClO3, MWT: 366.8375, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Indacaterol (maleate), Alternative-names: , CAS# 753498-25-8, Formula: C28H32N2O7, MWT: 508.5629, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| 2-Thiouracil, Alternative-names: Thiouracil, CAS# 141-90-2, Formula: C4H4N2OS, MWT: 128.1524, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Creatinine, Alternative-names: NSC13123, CAS# 60-27-5, Formula: C4H7N3O, MWT: 113.1179, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Moguisteine, Alternative-names: BBR-2173, CAS# 119637-67-1, Formula: C16H21NO5S, MWT: 339.4066, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Nadifloxacin, Alternative-names: OPC7251, CAS# 124858-35-1, Formula: C19H21FN2O4, MWT: 360.3795, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Sulfathiazole, Alternative-names: , CAS# 72-14-0, Formula: C9H9N3O2S2, MWT: 255.3167, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Sulfathiazole (sodium), Alternative-names: Soluthiazomide, CAS# 144-74-1, Formula: C9H8N3NaO2S2, MWT: 277.2985, Solubility: DMSO: ≥ 59 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Ornidazole, Alternative-names: Ro 7-0207, CAS# 16773-42-5, Formula: C7H10ClN3O3, MWT: 219.6256, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Anti-infection, Target: Bacterial;Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Vanoxerine (dihydrochloride), Alternative-names: GBR-12909 dihydrochloride;GBR12909 dihydrochloride;GBR 12909 dihydrochloride;I893 dihydrochloride;I-893 dihydrochloride;I 893 dihydrochloride, CAS# 67469-78-7, Formula: C28H32F2N2O, MWT: 450.5633, Solubility: DMSO: 9.4 mg/mL, Clinical_Information: Phase 3, Pathway: Neuronal Signaling, Target: Dopamine Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Vanoxerine, Alternative-names: GBR 12909;I893, CAS# 67469-69-6, Formula: C28H32F2N2O, MWT: 450.5633, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Neuronal Signaling, Target: Dopamine Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| RO4987655, Alternative-names: CH4987655, CAS# 874101-00-5, Formula: C20H19F3IN3O5, MWT: 565.2816, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Phase 1, Pathway: MAPK/ERK Pathway, Target: MEK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| Staurosporine, Alternative-names: Antibiotic AM-2282;STS;AM-2282, CAS# 62996-74-1, Formula: C28H26N4O3, MWT: 466.53104, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt;Protein Tyrosine Kinase/RTK;TGF-beta/Smad;Epigenetics, Target: PKA;PKA;PKC;PKC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| DBeQ, Alternative-names: JRF 12, CAS# 177355-84-9, Formula: C22H20N4, MWT: 340.421, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: p97, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Trimethoprim, Alternative-names: , CAS# 738-70-5, Formula: C14H18N4O3, MWT: 290.3177, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Antifolate, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Biotin, Alternative-names: Vitamin B7;Vitamin H;D-Biotin, CAS# 58-85-5, Formula: C10H16N2O3S, MWT: 244.3106, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Sulfamerazine, Alternative-names: RP2632, CAS# 127-79-7, Formula: C11H12N4O2S, MWT: 264.3036, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Sulfamerazine (sodium salt), Alternative-names: Soluble sulfamerazine, CAS# 127-58-2, Formula: C11H11N4NaO2S, MWT: 286.2854, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Sulfamethazine, Alternative-names: Sulfadimidine;Sulfadimerazine, CAS# 57-68-1, Formula: C12H14N4O2S, MWT: 278.3302, Solubility: DMSO: ≥100 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Methylthiouracil, Alternative-names: MTU, CAS# 56-04-2, Formula: C5H6N2OS, MWT: 142.1789, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: NF-κB, Target: NF-κB, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Ibandronate (Sodium Monohydrate), Alternative-names: , CAS# 138926-19-9, Formula: C9H24NNaO8P2, MWT: 359.226, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Ibandronic acid, Alternative-names: , CAS# 114084-78-5, Formula: C9H23NO7P2, MWT: 319.2289, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Ibandronate (Sodium), Alternative-names: , CAS# 138844-81-2, Formula: C9H22NNaO7P2, MWT: 341.2108, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Articaine (hydrochloride), Alternative-names: , CAS# 23964-57-0, Formula: C13H21ClN2O3S, MWT: 320.8354, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Mepivacaine (hydrochloride), Alternative-names: , CAS# 1722-62-9, Formula: C15H23ClN2O, MWT: 282.8089, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Naftifine (hydrochloride), Alternative-names: , CAS# 65473-14-5, Formula: C21H22ClN, MWT: 323.8591, Solubility: DMSO: <1 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| PF-04449913, Alternative-names: Glasdegib, CAS# 1095173-27-5, Formula: C21H22N6O, MWT: 374.439, Solubility: DMSO: ≥ 83.33 mg/mL, Clinical_Information: Phase 2, Pathway: Stem Cell/Wnt, Target: Smo, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tylosin (tartrate), Alternative-names: , CAS# 74610-55-2, Formula: C50H83NO23, MWT: 1066.187, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Benztropine (mesylate), Alternative-names: Benzatropine mesylate;Benzotropine mesylate;Benztropine methanesulfonate, CAS# 132-17-2, Formula: C22H29NO4S, MWT: 403.535, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Galanthaminone, Alternative-names: (-)-Narwedine;Narwedin, CAS# 510-77-0, Formula: C17H19NO3, MWT: 285.3376, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 25mg |
| SGI-1027, Alternative-names: , CAS# 1020149-73-8, Formula: C27H23N7O, MWT: 461.5178, Solubility: DMSO: 27 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics, Target: DNA Methyltransferase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| WP1066, Alternative-names: , CAS# 857064-38-1, Formula: C17H14BrN3O, MWT: 356.2166, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: Phase 1, Pathway: Epigenetics;Stem Cell/Wnt;JAK/STAT Signaling;JAK/STAT Signaling;Stem Cell/Wnt, Target: JAK;JAK;JAK;STAT;STAT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| VGX-1027, Alternative-names: GIT 27, CAS# 6501-72-0, Formula: C11H11NO3, MWT: 205.2099, Solubility: DMSO: ≥ 56 mg/mL, Clinical_Information: Phase 1, Pathway: Immunology/Inflammation, Target: Interleukin Related, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Y-320, Alternative-names: , CAS# 288250-47-5, Formula: C27H29ClN6O2, MWT: 505.0112, Solubility: DMSO: 5.5 mg/mL (Need ultrasonic), Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: Interleukin Related, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Mc-MMAE, Alternative-names: Maleimidocaproyl-monomethylauristatin E, CAS# 863971-24-8, Formula: C49H78N6O10, MWT: 911.1778, Solubility: DMSO: ≥ 51 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;Cytoskeleton;Antibody-drug Conjugate/ADC Related, Target: Microtubule/Tubulin;Microtubule/Tubulin;Drug-Linker Conjugates for ADC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Altrenogest, Alternative-names: A35957;Allyltrenbolone;R2267;RU2267, CAS# 850-52-2, Formula: C21H26O2, MWT: 310.4299, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Progesterone Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ampicillin, Alternative-names: D-(-)-α-Aminobenzylpenicillin, CAS# 69-53-4, Formula: C16H19N3O4S, MWT: 349.4048, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Ampicillin (sodium), Alternative-names: D-(-)-α-Aminobenzylpenicillin sodium salt, CAS# 69-52-3, Formula: C16H18N3NaO4S, MWT: 371.3866, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Anagrelide (hydrochloride), Alternative-names: BL4162A, CAS# 58579-51-4, Formula: C10H8Cl3N3O, MWT: 292.549, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Betahistine (dihydrochloride), Alternative-names: , CAS# 5579-84-0, Formula: C8H14Cl2N2, MWT: 209.1162, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Carbenicillin, Alternative-names: , CAS# 4697-36-3, Formula: C17H18N2O6S, MWT: 378.3996, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Carbenicillin (disodium), Alternative-names: Sodium carbenicillin, CAS# 4800-94-6, Formula: C17H16N2Na2O6S, MWT: 422.3633, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Flumequine, Alternative-names: , CAS# 42835-25-6, Formula: C14H12FNO3, MWT: 261.2484, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;Anti-infection, Target: Topoisomerase;Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| SB-334867 (free base), Alternative-names: SB334867A free base, CAS# 792173-99-0, Formula: C17H13N5O2, MWT: 319.3174, Solubility: DMSO: ≥ 49 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Orexin Receptor (OX Receptor), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| U-73122, Alternative-names: , CAS# 112648-68-7, Formula: C29H40N2O3, MWT: 464.6395, Solubility: DMSO: < 4.8 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease;Metabolic Enzyme/Protease, Target: 5-Lipoxygenase;Phospholipase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Vigabatrin (Hydrochloride), Alternative-names: γ-Vinyl-GABA hydrochloride, CAS# 1391054-02-6, Formula: C6H12ClNO2, MWT: 165.618, Solubility: DMSO: 27.5 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Amitriptyline (hydrochloride), Alternative-names: , CAS# 549-18-8, Formula: C20H24ClN, MWT: 313.8643, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Octopamine (hydrochloride), Alternative-names: (¡À)-p-Octopamine hydrochlorid, CAS# 770-05-8, Formula: C8H12ClNO2, MWT: 189.6394, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Azlocillin (sodium salt), Alternative-names: Sodium azlocillin, CAS# 37091-65-9, Formula: C20H22N5NaO6S, MWT: 483.4734, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Azacyclonol, Alternative-names: γ-pipradol, CAS# 115-46-8, Formula: C18H21NO, MWT: 267.3654, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Triflusal, Alternative-names: , CAS# 322-79-2, Formula: C10H7F3O4, MWT: 248.1554, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Trifluoperazine (dihydrochloride), Alternative-names: TFP;SKF5019, CAS# 440-17-5, Formula: C21H26Cl2F3N3S, MWT: 480.4174, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Catharanthine, Alternative-names: (+)-3,4-Didehydrocoronaridine, CAS# 2468-21-5, Formula: C21H24N2O2, MWT: 336.4275, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: nAChR;nAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Latanoprost, Alternative-names: , CAS# 130209-82-4, Formula: C26H40O5, MWT: 432.5928, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Doxorubicin, Alternative-names: Adriamycin;Hydroxydaunorubicin, CAS# 23214-92-8, Formula: C27H29NO11, MWT: 543.5193, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Antibody-drug Conjugate/ADC Related;Autophagy, Target: Topoisomerase;ADC Cytotoxin;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Loxoprofen, Alternative-names: , CAS# 68767-14-6, Formula: C15H18O3, MWT: 246.3016, Solubility: DMSO: ≥ 125 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cyclosporin A, Alternative-names: Cyclosporine;Ciclosporin, CAS# 59865-13-3, Formula: C62H111N11O12, MWT: 1202.611, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ketorolac, Alternative-names: RS37619, CAS# 74103-06-3, Formula: C15H13NO3, MWT: 255.2686, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| R-(-)-Deprenyl (hydrochloride), Alternative-names: Selegiline hydrochloride;L-Deprenyl hydrochloride, CAS# 14611-52-0, Formula: C13H18ClN, MWT: 223.7417, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Vardenafil (hydrochloride), Alternative-names: , CAS# 224785-91-5, Formula: C23H33ClN6O4S, MWT: 525.0639, Solubility: DMSO: ≥ 53 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| VX-765, Alternative-names: Belnacasan, CAS# 273404-37-8, Formula: C24H33ClN4O6, MWT: 508.995, Solubility: DMSO: ≥ 27 mg/mL, Clinical_Information: Phase 2, Pathway: Apoptosis, Target: Caspase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Oprozomib, Alternative-names: ONX 0912;PR-047, CAS# 935888-69-0, Formula: C25H32N4O7S, MWT: 532.6092, Solubility: DMSO: ≥ 50 mg/mL, Clinical_Information: Phase 2, Pathway: Metabolic Enzyme/Protease;Autophagy, Target: Proteasome;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Ruxolitinib (S enantiomer), Alternative-names: S-Ruxolitinib;INCB18424, CAS# 941685-37-6, Formula: C17H18N6, MWT: 306.36502, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Epigenetics;Stem Cell/Wnt;JAK/STAT Signaling;Autophagy, Target: JAK;JAK;JAK;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Dexrazoxane, Alternative-names: ICRF187;NSC169780, CAS# 24584-09-6, Formula: C11H16N4O4, MWT: 268.2691, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Reboxetine (mesylate), Alternative-names: FCE20124 mesylate;PNU155950E mesylate, CAS# 98769-84-7, Formula: C20H27NO6S, MWT: 409.49648, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Nedaplatin, Alternative-names: , CAS# 95734-82-0, Formula: C2H8N2O3Pt, MWT: 303.18052, Solubility: DMSO: <1 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: DNA/RNA Synthesis, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
Travoprost, Alternative-names:
Fluprostenol isopropyl ester;AL6221;Flu-Ipr, CAS# 157283-68-6, Formula: C26H35F3O6, MWT: 500.5477, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Piracetam, Alternative-names: , CAS# 7491-74-9, Formula: C6H10N2O2, MWT: 142.1558, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel;Neuronal Signaling, Target: iGluR;iGluR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Methylcobalamin, Alternative-names: , CAS# 13422-55-4, Formula: C63H91CoN13O14P, MWT: 1344.382297, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Miglustat, Alternative-names: N-Butyldeoxynojirimycin;NB-DNJ;OGT918, CAS# 72599-27-0, Formula: C10H21NO4, MWT: 219.278, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Miglustat (hydrochloride), Alternative-names: N-Butyldeoxynojirimycin, Hydrochloride;NB-DNJ hydrochloride;OGT918 hydrochloride, CAS# 210110-90-0, Formula: C10H22ClNO4, MWT: 255.739, Solubility: H<sub>2</sub>O: ≥ 34 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Amifampridine, Alternative-names: 3,4-Diaminopyridine, CAS# 54-96-6, Formula: C5H7N3, MWT: 109.1292, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| CGP 57380, Alternative-names: , CAS# 522629-08-9, Formula: C11H9FN6, MWT: 244.2278, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: No Development Reported, Pathway: MAPK/ERK Pathway, Target: MNK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Rucaparib (phosphate), Alternative-names: AG-014699 phosphate;PF-01367338 phosphate, CAS# 459868-92-9, Formula: C19H21FN3O5P, MWT: 421.3593, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: PARP;PARP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Tirapazamine, Alternative-names: SR259075;SR4233;Win59075, CAS# 27314-97-2, Formula: C7H6N4O2, MWT: 178.1481, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: Phase 3, Pathway: Cell Cycle/DNA Damage, Target: Topoisomerase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| CNX-2006, Alternative-names: , CAS# 1375465-09-0, Formula: C26H27F4N7O2, MWT: 545.5319, Solubility: DMSO: ≥ 52 mg/mL, Clinical_Information: No Development Reported, Pathway: JAK/STAT Signaling;Protein Tyrosine Kinase/RTK, Target: EGFR;EGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tirasemtiv, Alternative-names: CK-2017357, CAS# 1005491-05-3, Formula: C12H14N4O, MWT: 230.2658, Solubility: DMSO: ≥ 52 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| AMD 3465 (hexahydrobromide), Alternative-names: GENZ-644494 hexahydrobromide, CAS# 185991-07-5, Formula: C24H44Br6N6, MWT: 896.07036, Solubility: H<sub>2</sub>O: ≥ 38 mg/mL, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Immunology/Inflammation, Target: CXCR;CXCR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Rucaparib, Alternative-names: AG014699;PF-01367338, CAS# 283173-50-2, Formula: C19H18FN3O, MWT: 323.3641, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: PARP;PARP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| AMD 3465, Alternative-names: GENZ-644494, CAS# 185991-24-6, Formula: C24H38N6, MWT: 410.5987, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: GPCR/G Protein;Immunology/Inflammation, Target: CXCR;CXCR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Guanfacine, Alternative-names: , CAS# 29110-47-2, Formula: C9H9Cl2N3O, MWT: 246.0933, Solubility: DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Brinzolamide, Alternative-names: AL-4862, CAS# 138890-62-7, Formula: C12H21N3O5S3, MWT: 383.5072, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Carbonic Anhydrase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
GSK269962A, Alternative-names: GSK 269962, CAS# 850664-21-0, Formula: C29H30N8O5, MWT: 570.5991, Solubility: DMSO: ≥ 30 mg/mL
, Clinical_Information: No Development Reported, Pathway: TGF-beta/Smad;Stem Cell/Wnt;Cell Cycle/DNA Damage, Target: ROCK;ROCK;ROCK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| GS-9973, Alternative-names: Entospletinib, CAS# 1229208-44-9, Formula: C23H21N7O, MWT: 411.4591, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Phase 2, Pathway: Protein Tyrosine Kinase/RTK, Target: Syk, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Actinomycin D, Alternative-names: Dactinomycin;Actinomycin IV, CAS# 50-76-0, Formula: C62H86N12O16, MWT: 1255.417, Solubility: DMSO: ≥ 27 mg/mL; DMSO: 250 mg/mL (Need ultrasonic); Methanol: 6.2 mg/mL; Methanol: 20 mg/mL (Need ultrasonic); H<sub>2</sub>O: < 12.5 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Autophagy, Target: DNA/RNA Synthesis;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Eperezolid, Alternative-names: PNU-100592, CAS# 165800-04-4, Formula: C18H23FN4O5, MWT: 394.3974, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Betulinaldehyde, Alternative-names: Betulinic aldehyde;Betunal, CAS# 13159-28-9, Formula: C30H48O2, MWT: 440.70092, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| GNF179 (Metabolite), Alternative-names: , CAS# 1310455-86-7, Formula: C14H16FN3, MWT: 245.2953, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| GNF179, Alternative-names: , CAS# 1261114-01-5, Formula: C22H23ClFN5O, MWT: 427.9023, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Arctigenin, Alternative-names: (-)-Arctigenin, CAS# 7770-78-7, Formula: C21H24O6, MWT: 372.4117, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease;Autophagy, Target: MMP;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Atorvastatin, Alternative-names: , CAS# 134523-00-5, Formula: C33H35FN2O5, MWT: 558.6398, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: HMG-CoA Reductase (HMGCR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Cysteamine, Alternative-names: β-MEA;β-Mercaptoethylamine;2-Aminoethanethiol;2-Mercaptoethylamine;Decarboxycysteine;MEA;Thioethanolamine, CAS# 60-23-1, Formula: C2H7NS, MWT: 77.14868, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Cysteamine (Hydrochloride), Alternative-names: β-MEA Hydrochloride;β-Mercaptoethylamine Hydrochloride;2-Aminoethanethiol Hydrochloride;2-Mercaptoethylamine Hydrochloride;Decarboxycysteine Hydrochloride;MEA Hydrochloride;Thioethanolamine Hydrochloride, CAS# 156-57-0, Formula: C2H8ClNS, MWT: 113.6096, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Tetrabenazine, Alternative-names: Ro 1-9569, CAS# 58-46-8, Formula: C19H27NO3, MWT: 317.42258, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Monoamine Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Eribulin, Alternative-names: B1939;E7389;ER-086526, CAS# 253128-41-5, Formula: C40H59NO11, MWT: 729.8965, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Cytoskeleton, Target: Microtubule/Tubulin;Microtubule/Tubulin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Eribulin (mesylate), Alternative-names: B1939 mesylate;E7389 mesylate;ER-086526 mesylate, CAS# 441045-17-6, Formula: C41H63NO14S, MWT: 826.0022, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Cytoskeleton, Target: Microtubule/Tubulin;Microtubule/Tubulin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500ug |
| Cabergoline, Alternative-names: FCE-21336, CAS# 81409-90-7, Formula: C26H37N5O2, MWT: 451.6043, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;Autophagy, Target: Dopamine Receptor;Dopamine Receptor;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| TPT-260 (Dihydrochloride), Alternative-names: NSC55712;TPU-260 Dihydrochloride, CAS# 2076-91-7, Formula: C8H14Cl2N4S3, MWT: 333.3246, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| TPT-260, Alternative-names: TPU260, CAS# 769856-81-7, Formula: C8H12N4S3, MWT: 260.4027, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| LGK974, Alternative-names: , CAS# 1243244-14-5, Formula: C23H20N6O, MWT: 396.4445, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Phase 1, Pathway: Stem Cell/Wnt, Target: Porcupine, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| DDR1-IN-1, Alternative-names: , CAS# 1449685-96-4, Formula: C30H31F3N4O3, MWT: 552.5873, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: Discoidin Domain Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Trandolapril, Alternative-names: RU44570, CAS# 87679-37-6, Formula: C24H34N2O5, MWT: 430.5372, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ceftazidime, Alternative-names: GR20263, CAS# 72558-82-8, Formula: C22H22N6O7S2, MWT: 546.576, Solubility: DMSO: ≥ 55 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Iohexol, Alternative-names: , CAS# 66108-95-0, Formula: C19H26I3N3O9, MWT: 821.1379, Solubility: DMSO: ≥ 46 mg/mL, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Telithromycin, Alternative-names: HMR3647;RU66647, CAS# 191114-48-4, Formula: C43H65N5O10, MWT: 812.0037, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ramosetron (Hydrochloride), Alternative-names: YM060, CAS# 132907-72-3, Formula: C17H18ClN3O, MWT: 315.7973, Solubility: DMSO: 22 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Taltirelin, Alternative-names: TA-0910, CAS# 103300-74-9, Formula: C17H23N7O5, MWT: 405.4084, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Salmeterol, Alternative-names: GR33343X, CAS# 89365-50-4, Formula: C25H37NO4, MWT: 415.5656, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Camostat (mesylate), Alternative-names: Camostat mesilate;FOY305;FOY-S980, CAS# 59721-29-8, Formula: C21H26N4O8S, MWT: 494.5181, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tafluprost, Alternative-names: AFP-168;MK2452, CAS# 209860-87-7, Formula: C25H34F2O5, MWT: 452.5313, Solubility: DMSO: 16.5 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Desvenlafaxine, Alternative-names: O-Desmethylvenlafaxine, CAS# 93413-62-8, Formula: C16H25NO2, MWT: 263.3752, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Acetaminophen, Alternative-names: Paracetamol;4'-Hydroxyacetanilide;4-Acetamidophenol;APAP, CAS# 103-90-2, Formula: C8H9NO2, MWT: 151.1626, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| (R)-Lansoprazole, Alternative-names: Dexlansoprazole, CAS# 138530-94-6, Formula: C16H14F3N3O2S, MWT: 369.3615, Solubility: DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Proton Pump, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Tafamidis, Alternative-names: Fx-1006A;Fx1006A;Fx 1006A, CAS# 594839-88-0, Formula: C14H7Cl2NO3, MWT: 308.1163, Solubility: DMSO: ≥ 54 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| 4-Aminopyridine, Alternative-names: 4-AP;4-Pyridinamine;Fampridine, CAS# 504-24-5, Formula: C5H6N2, MWT: 94.11454, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| Epirubicin, Alternative-names: , CAS# 56420-45-2, Formula: C27H29NO11, MWT: 543.5193, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Topoisomerase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Nitisinone, Alternative-names: NTBC;Nitisone;SC0735, CAS# 104206-65-7, Formula: C14H10F3NO5, MWT: 329.2281, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Chlorhexidine (digluconate), Alternative-names: , CAS# 18472-51-0, Formula: C34H54Cl2N10O14, MWT: 897.7571, Solubility: DMSO: ≥ 38 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Misoprostol, Alternative-names: SC-29333, CAS# 59122-46-2, Formula: C22H38O5, MWT: 382.5341, Solubility: DMSO: 6.4 mg/mL (Need ultrasonic and warming), Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Tirofiban, Alternative-names: L700462;MK383, CAS# 144494-65-5, Formula: C22H36N2O5S, MWT: 440.5966, Solubility: DMSO: < 1 mg/mL, Clinical_Information: Launched, Pathway: Cytoskeleton, Target: Integrin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Lercanidipine, Alternative-names: , CAS# 100427-26-7, Formula: C36H41N3O6, MWT: 611.7272, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Lercanidipine (hydrochloride), Alternative-names: , CAS# 132866-11-6, Formula: C36H42ClN3O6, MWT: 648.1882, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Calcium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Bilastine, Alternative-names: , CAS# 202189-78-4, Formula: C28H37N3O3, MWT: 463.6117, Solubility: DMSO: ≥ 49.3 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Fasudil, Alternative-names: HA-1077;AT877, CAS# 103745-39-7, Formula: C14H17N3O2S, MWT: 291.3687, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: TGF-beta/Smad;Epigenetics;TGF-beta/Smad;Stem Cell/Wnt;Cell Cycle/DNA Damage;Autophagy, Target: PKC;PKC;ROCK;ROCK;ROCK;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Amiodarone, Alternative-names: , CAS# 1951-25-3, Formula: C25H29I2NO3, MWT: 645.3116, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy;Membrane Transporter/Ion Channel, Target: Autophagy;Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Clevudine, Alternative-names: , CAS# 163252-36-6, Formula: C10H13FN2O5, MWT: 260.219, Solubility: DMSO: ≥ 50 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: HBV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Amrubicin, Alternative-names: AMR, CAS# 110267-81-7, Formula: C25H25NO9, MWT: 483.4673, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Topoisomerase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Amrubicin (hydrochloride), Alternative-names: AMR hydrochloride, CAS# 110311-30-3, Formula: C25H26ClNO9, MWT: 519.9282, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Topoisomerase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Mafenide, Alternative-names: , CAS# 138-39-6, Formula: C7H10N2O2S, MWT: 186.2315, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Mafenide (Acetate), Alternative-names: , CAS# 13009-99-9, Formula: C9H14N2O4S, MWT: 246.2835, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Moricizine, Alternative-names: Moracizine, CAS# 31883-05-3, Formula: C22H25N3O4S, MWT: 427.5166, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cefepime (Dihydrochloride Monohydrate), Alternative-names: , CAS# 123171-59-5, Formula: C19H28Cl2N6O6S2, MWT: 571.4982, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL; DMSO: < 11.8 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Alcaftadine, Alternative-names: R89674, CAS# 147084-10-4, Formula: C19H21N3O, MWT: 307.3895, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| (R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid, Alternative-names: D-phenylalanine analogue, CAS# 103733-65-9, Formula: C10H11NO2, MWT: 177.1998, Solubility: 10 mM in DMSO; H<sub>2</sub>O: < 6.2 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| VER-50589, Alternative-names: , CAS# 747413-08-7, Formula: C19H17ClN2O5, MWT: 388.8017, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease;Cell Cycle/DNA Damage, Target: HSP;HSP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| VER-49009, Alternative-names: CCT 129397, CAS# 558640-51-0, Formula: C19H18ClN3O4, MWT: 387.8169, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease;Cell Cycle/DNA Damage, Target: HSP;HSP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Maribavir, Alternative-names: 1263W94;BW1263W94;GW257406X, CAS# 176161-24-3, Formula: C15H19Cl2N3O4, MWT: 376.235, Solubility: DMSO: ≥ 51 mg/mL, Clinical_Information: Phase 3, Pathway: Anti-infection, Target: CMV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| DUBs-IN-3, Alternative-names: , CAS# 924296-17-3, Formula: C16H9N5O, MWT: 287.27556, Solubility: DMSO: 20.1 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: Deubiquitinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| DUBs-IN-2, Alternative-names: , CAS# 924296-19-5, Formula: C15H9N5O, MWT: 275.2649, Solubility: DMSO: 9.06 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: Deubiquitinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| DUBs-IN-1, Alternative-names: , CAS# 924296-18-4, Formula: C20H11N5O, MWT: 337.3342, Solubility: DMSO: 20 mg/mL, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage, Target: Deubiquitinase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Ademetionine, Alternative-names: S-Adenosyl-L-methionine;S-Adenosyl methionine;SAMe;AdoMet, CAS# 29908-03-0, Formula: C15H22N6O5S, MWT: 398.4374, Solubility: H<sub>2</sub>O: ≥ 43 mg/mL; DMSO: ≥100 mg/mL (Need ultrasonic), Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Mirodenafil, Alternative-names: SK3530, CAS# 862189-95-5, Formula: C26H37N5O5S, MWT: 531.6675, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Nimorazole, Alternative-names: , CAS# 6506-37-2, Formula: C9H14N4O3, MWT: 226.2325, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Zaltoprofen, Alternative-names: CN100, CAS# 74711-43-6, Formula: C17H14O3S, MWT: 298.3563, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Sibutramine (hydrochloride), Alternative-names: BTS 54-524, CAS# 84485-00-7, Formula: C17H27Cl2N, MWT: 316.309, Solubility: DMSO: ≥ 57 mg/mL, Clinical_Information: Phase 4, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: Serotonin Transporter;Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Sibutramine (hydrochloride monohydrate), Alternative-names: BTS 54-524 hydrochloride monohydrate, CAS# 125494-59-9, Formula: C17H29Cl2NO, MWT: 334.3242, Solubility: DMSO, Clinical_Information: Phase 4, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: Serotonin Transporter;Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Triclabendazole, Alternative-names: CGA89317, CAS# 68786-66-3, Formula: C14H9Cl3N2OS, MWT: 359.6581, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;Cytoskeleton, Target: Microtubule/Tubulin;Microtubule/Tubulin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Talipexole, Alternative-names: B-HT 920;B-HT920, CAS# 101626-70-4, Formula: C10H15N3S, MWT: 209.3112, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Fluoxetine, Alternative-names: LY-110140, CAS# 54910-89-3, Formula: C17H18F3NO, MWT: 309.3261, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Autophagy, Target: Serotonin Transporter;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Diclofenac, Alternative-names: , CAS# 15307-86-5, Formula: C14H11Cl2NO2, MWT: 296.1487, Solubility: DMSO: ≥ 3.5 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| PPQ-102, Alternative-names: CFTR Inhibitor, CAS# 931706-15-9, Formula: C26H22N4O3, MWT: 438.4779, Solubility: DMSO: ≥ 52 mg/mL, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: CFTR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ropinirole (hydrochloride), Alternative-names: SKF 101468 hydrochloride, CAS# 91374-20-8, Formula: C16H25ClN2O, MWT: 296.8355, Solubility: DMSO: 17 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Voglibose, Alternative-names: , CAS# 83480-29-9, Formula: C10H21NO7, MWT: 267.2762, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Donepezil, Alternative-names: E2020, CAS# 120014-06-4, Formula: C24H29NO3, MWT: 379.492, Solubility: DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Ciclesonide, Alternative-names: RPR251526, CAS# 126544-47-6, Formula: C32H44O7, MWT: 540.6876, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Vinflunine, Alternative-names: , CAS# 162652-95-1, Formula: C45H54F2N4O8, MWT: 816.9291, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Cytoskeleton, Target: Microtubule/Tubulin;Microtubule/Tubulin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Aceclofenac, Alternative-names: , CAS# 89796-99-6, Formula: C16H13Cl2NO4, MWT: 354.1847, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: COX, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Tamoxifen, Alternative-names: ICI47699;Z-Tamoxifen;trans-Tamoxifen, CAS# 10540-29-1, Formula: C26H29NO, MWT: 371.5146, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Others;Autophagy, Target: Estrogen Receptor/ERR;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Triamcinolone (acetonide), Alternative-names: , CAS# 76-25-5, Formula: C24H31FO6, MWT: 434.4977, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Homoharringtonine, Alternative-names: Omacetaxine mepesuccinate;HHT, CAS# 26833-87-4, Formula: C29H39NO9, MWT: 545.62126, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: JAK/STAT Signaling;Stem Cell/Wnt, Target: STAT;STAT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Paroxetine (hydrochloride hemihydrate), Alternative-names: BRL29060 hydrochloride hemihydrate;BRL29060A hemihydrate, CAS# 110429-35-1, Formula: C19H20FNO3.Cl H.1/2H2O, MWT: 374.8339832, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Autophagy, Target: Serotonin Transporter;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Bezafibrate, Alternative-names: BM15075, CAS# 41859-67-0, Formula: C19H20ClNO4, MWT: 361.8194, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;NF-κB, Target: PPAR;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amifostine, Alternative-names: WR2721, CAS# 20537-88-6, Formula: C5H15N2O3PS, MWT: 214.223, Solubility: H<sub>2</sub>O: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Epinastine, Alternative-names: WAL801, CAS# 80012-43-7, Formula: C16H15N3, MWT: 249.3104, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dirithromycin, Alternative-names: LY237216, CAS# 62013-04-1, Formula: C42H78N2O14, MWT: 835.0737, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Prednisolone (disodium phosphate), Alternative-names: Prednisolone 21-phosphate disodium, CAS# 125-02-0, Formula: C21H27Na2O8P, MWT: 484.3876, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Glucocorticoid Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Lomefloxacin, Alternative-names: SC47111A, CAS# 98079-51-7, Formula: C17H19F2N3O3, MWT: 351.3479, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Diacerein, Alternative-names: Diacerhein;Diacetylrhein;Fisiodar;Artrodar, CAS# 13739-02-1, Formula: C19H12O8, MWT: 368.2938, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: Interleukin Related, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Miconazole (nitrate), Alternative-names: R18134 nitrate, CAS# 22832-87-7, Formula: C18H15Cl4N3O4, MWT: 479.1414, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Medroxyprogesterone, Alternative-names: 17α-Hydroxy-6α-methylprogesterone;U8840, CAS# 520-85-4, Formula: C22H32O3, MWT: 344.4877, Solubility: DMSO: 10.5 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Progesterone Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Azelastine, Alternative-names: , CAS# 58581-89-8, Formula: C22H24ClN3O, MWT: 381.8985, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Etonogestrel, Alternative-names: 3-Oxodesogestrel;3-keto-Desogestrel, CAS# 54048-10-1, Formula: C22H28O2, MWT: 324.4565, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others;Others, Target: Progesterone Receptor;Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Duloxetine, Alternative-names: (S)-Duloxetine;LY248686, CAS# 116539-59-4, Formula: C18H19NOS, MWT: 297.4146, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Zofenopril (calcium), Alternative-names: SQ26991, CAS# 81938-43-4, Formula: C22H22Ca0.5NO4S2, MWT: 448.58, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Topotecan, Alternative-names: SKF104864, CAS# 123948-87-8, Formula: C23H23N3O5, MWT: 421.4458, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Autophagy, Target: Topoisomerase;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Rabeprazole, Alternative-names: LY307640, CAS# 117976-89-3, Formula: C18H21N3O3S, MWT: 359.4426, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Proton Pump, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Rabeprazole (sodium), Alternative-names: LY307640 sodium, CAS# 117976-90-6, Formula: C18H21N3NaO3S+, MWT: 382.4318607, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Proton Pump, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Doxycycline (hyclate), Alternative-names: Doxycycline hydrochloride hemiethanolate hemihydrate;WC2031, CAS# 24390-14-5, Formula: C22H25ClN2O8, MWT: 480.8955, Solubility: H<sub>2</sub>O: 26 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: MMP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Cyproterone (acetate), Alternative-names: , CAS# 427-51-0, Formula: C23H27ClO4, MWT: 402.91108, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 250mg |
| UK 14,304, Alternative-names: Brimonidine;AGN190342;UK14304, CAS# 59803-98-4, Formula: C11H10BrN5, MWT: 292.1346, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Candesartan (Cilexetil), Alternative-names: TCV-116, CAS# 145040-37-5, Formula: C33H34N6O6, MWT: 610.6597, Solubility: DMSO：≥ 50 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Angiotensin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Raltitrexed, Alternative-names: ZD1694;D1694;ICI-D1694, CAS# 112887-68-0, Formula: C21H22N4O6S, MWT: 458.48758, Solubility: DMSO: ≥ 29 mg/mL, Clinical_Information: Launched, Pathway: Apoptosis;Cell Cycle/DNA Damage, Target: Thymidylate Synthase;Nucleoside Antimetabolite/Analog, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
Eicosapentaenoic Acid, Alternative-names: EPA;Timnodonic acid, CAS# 10417-94-4, Formula: C20H30O2, MWT: 302.451, Solubility: DMSO: ≥ 53 mg/mL
, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tamsulosin, Alternative-names: , CAS# 106133-20-4, Formula: C20H28N2O5S, MWT: 408.5117, Solubility: DMSO: ≥ 51.9 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Tamsulosin (hydrochloride), Alternative-names: (R)-(-)-YM12617;LY253351, CAS# 106463-17-6, Formula: C20H29ClN2O5S, MWT: 444.9727, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ciprofibrate, Alternative-names: Win35833, CAS# 52214-84-3, Formula: C13H14Cl2O3, MWT: 289.1544, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;NF-κB, Target: PPAR;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Balsalazide, Alternative-names: , CAS# 80573-04-2, Formula: C17H15N3O6, MWT: 357.3175, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation;JAK/STAT Signaling;Stem Cell/Wnt, Target: Interleukin Related;STAT;STAT, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Fingolimod, Alternative-names: FTY720 free base, CAS# 162359-55-9, Formula: C19H33NO2, MWT: 307.4708, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: SPHK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Rasagiline, Alternative-names: AGN1135;TVP1012, CAS# 136236-51-6, Formula: C12H13N, MWT: 171.2383, Solubility: DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Monoamine Oxidase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Temoporfin, Alternative-names: m-THPC;KW2345, CAS# 122341-38-2, Formula: C44H32N4O4, MWT: 680.7493, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Dihydroergotamine (mesylate), Alternative-names: , CAS# 6190-39-2, Formula: C34H41N5O8S, MWT: 679.783, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| β-Estradiol 17-valerate, Alternative-names: Estradiol valerianate, CAS# 979-32-8, Formula: C23H32O3, MWT: 356.4984, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Pirfenidone, Alternative-names: AMR69, CAS# 53179-13-8, Formula: C12H11NO, MWT: 185.2218, Solubility: DMSO: 171.66 mg/mL (Need ultrasonic), Clinical_Information: Launched, Pathway: Stem Cell/Wnt;TGF-beta/Smad, Target: TGF-beta/Smad;TGF-beta/Smad, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Ebastine, Alternative-names: LAS-W 090;RP64305, CAS# 90729-43-4, Formula: C32H39NO2, MWT: 469.6576, Solubility: 10 mM in DMSO, Clinical_Information: Phase 4, Pathway: Immunology/Inflammation;GPCR/G Protein, Target: Histamine Receptor;Histamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Etizolam, Alternative-names: AHR3219;Y7131, CAS# 40054-69-1, Formula: C17H15ClN4S, MWT: 342.8458, Solubility: DMSO: 13.5 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Metaxalone, Alternative-names: AHR438;NSC170959, CAS# 1665-48-1, Formula: C12H15NO3, MWT: 221.2524, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Lubiprostone, Alternative-names: RU-0211;SPI-0211, CAS# 136790-76-6, Formula: C20H32F2O5, MWT: 390.4619, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Chloride Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Limaprost, Alternative-names: 17α,20-dimethyl-δ2-PGE1;ONO1206;OP1206, CAS# 74397-12-9, Formula: C22H36O5, MWT: 380.5182, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: Launched, Pathway: Immunology/Inflammation, Target: PGE synthase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 2mg |
| Pixantrone, Alternative-names: BBR 2778, CAS# 144510-96-3, Formula: C17H19N5O2, MWT: 325.3651, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Cell Cycle/DNA Damage, Target: Topoisomerase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sitagliptin, Alternative-names: MK0431, CAS# 486460-32-6, Formula: C16H15F6N5O, MWT: 407.3136, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Autophagy, Target: Dipeptidyl Peptidase;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sitagliptin (phosphate), Alternative-names: MK0431 phosphate, CAS# 654671-78-0, Formula: C16H18F6N5O5P, MWT: 505.3088, Solubility: 10 mM in DMSO; 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Autophagy, Target: Dipeptidyl Peptidase;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sarpogrelate (hydrochloride), Alternative-names: MCI-9042, CAS# 135159-51-2, Formula: C24H32ClNO6, MWT: 465.967, Solubility: DMSO: ≥ 62 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Iopamidol, Alternative-names: , CAS# 60166-93-0, Formula: C17H22I3N3O8, MWT: 777.0853, Solubility: H<sub>2</sub>O: ≥ 8.2 mg/mL; DMSO: < 8 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Enalapril, Alternative-names: , CAS# 75847-73-3, Formula: C20H28N2O5, MWT: 376.4467, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Angiotensin-converting Enzyme (ACE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Sivelestat, Alternative-names: EI546;LY544349;ONO5046, CAS# 127373-66-4, Formula: C20H22N2O7S, MWT: 434.4629, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Elastase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Sivelestat (sodium), Alternative-names: ONO5046-Na;Sodium sivelestat;EI546 sodium;LY544349 sodium, CAS# 150374-95-1, Formula: C20H21N2NaO7S, MWT: 456.4447, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Elastase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Bedaquiline, Alternative-names: TMC207;R207910, CAS# 843663-66-1, Formula: C32H31BrN2O2, MWT: 555.5048, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Bedaquiline (fumarate), Alternative-names: R403323;TMC207 fumarate;R207910 fumarate, CAS# 845533-86-0, Formula: C36H35BrN2O6, MWT: 671.5769, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Atractyloside A, Alternative-names: , CAS# 126054-77-1, Formula: C21H36O10, MWT: 448.5045, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Rimantadine (hydrochloride), Alternative-names: , CAS# 1501-84-4, Formula: C12H22ClN, MWT: 215.7628, Solubility: DMSO: ≥ 2.5 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Influenza Virus, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Eptifibatide, Alternative-names: MPA-HAR-Gly-Asp-Trp-Pro-Cys-NH2;{MPA}{HAR}GDWPC-NH2, CAS# 188627-80-7, Formula: C35H49N11O9S2, MWT: 831.9619, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Cytoskeleton, Target: Integrin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Warfarin, Alternative-names: WARF42;Athrombine-K, CAS# 81-81-2, Formula: C19H16O4, MWT: 308.3279, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Atenolol, Alternative-names: (RS)-Atenolol, CAS# 29122-68-7, Formula: C14H22N2O3, MWT: 266.3361, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Dapsone, Alternative-names: Dapson;4,4′-Diaminodiphenyl sulfone;4,4′-Sulfonyldianiline;4-Aminophenyl sulfone;Bis(4-aminophenyl) sulfone;DDS, CAS# 80-08-0, Formula: C12H12N2O2S, MWT: 248.3009, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Valrubicin, Alternative-names: AD-32, CAS# 56124-62-0, Formula: C34H36F3NO13, MWT: 723.6437, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: TGF-beta/Smad;Epigenetics, Target: PKC;PKC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Indinavir, Alternative-names: MK-639;L-735524, CAS# 150378-17-9, Formula: C36H47N5O4, MWT: 613.7895, Solubility: DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Anti-infection, Target: HIV Protease;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Indinavir (sulfate), Alternative-names: MK-639 sulfate;L735524 sulfate, CAS# 157810-81-6, Formula: C36H49N5O8S, MWT: 711.868, Solubility: DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Anti-infection, Target: HIV Protease;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Sertindole, Alternative-names: Lu 23-174, CAS# 106516-24-9, Formula: C24H26ClFN4O, MWT: 440.9409, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling;Autophagy;Neuronal Signaling;GPCR/G Protein, Target: Dopamine Receptor;Dopamine Receptor;Autophagy;5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Miltefosine, Alternative-names: HePC;Hexadecyl phosphocholine, CAS# 58066-85-6, Formula: C21H46NO4P, MWT: 407.568, Solubility: DMSO: < 4.4 mg/mL, Clinical_Information: Launched, Pathway: PI3K/Akt/mTOR;Anti-infection, Target: Akt;HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Carmustine, Alternative-names: , CAS# 154-93-8, Formula: C5H9Cl2N3O2, MWT: 214.0499, Solubility: DMSO: ≥ 35 mg/mL; H<sub>2</sub>O: < 6 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: DNA Alkylator/Crosslinker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tiagabine, Alternative-names: NO050328;NO328;TGB, CAS# 115103-54-3, Formula: C20H25NO2S2, MWT: 375.548, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Tiagabine (hydrochloride), Alternative-names: NO050328 hydrochloride;NO328 hydrochloride;TGB hydrochloride, CAS# 145821-59-6, Formula: C20H26ClNO2S2, MWT: 412.0089, Solubility: DMSO: ≥ 53 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ceftibuten, Alternative-names: Sch 39720, CAS# 97519-39-6, Formula: C15H14N4O6S2, MWT: 410.4249, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Nicergoline, Alternative-names: , CAS# 27848-84-6, Formula: C24H26BrN3O3, MWT: 484.3855, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Eslicarbazepine (acetate), Alternative-names: BIA 2-093, CAS# 236395-14-5, Formula: C17H16N2O3, MWT: 296.3205, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: Beta-secretase;Sodium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Udenafil, Alternative-names: DA8159, CAS# 268203-93-6, Formula: C25H36N6O4S, MWT: 516.6561, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Mifamurtide, Alternative-names: CGP-19835;MTP-PE;MTP-cephalin;CGP19835;L-MTP-PE;MLV19835, CAS# 83461-56-7, Formula: C59H109N6O19P, MWT: 1237.499322, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| β-Estradiol 17-acetate, Alternative-names: 1,3,5(10)-Estratriene-3,17β-diol 17-acetate, CAS# 1743-60-8, Formula: C20H26O3, MWT: 314.4186, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Estrogen Receptor/ERR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Ceftriaxone, Alternative-names: , CAS# 73384-59-5, Formula: C18H18N8O7S3, MWT: 554.5799, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Amlexanox, Alternative-names: AA673;Amoxanox;CHX3673, CAS# 68302-57-8, Formula: C16H14N2O4, MWT: 298.2934, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: Launched, Pathway: NF-κB, Target: IKK, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Prulifloxacin, Alternative-names: NM441, CAS# 123447-62-1, Formula: C21H20FN3O6S, MWT: 461.4634, Solubility: DMSO: 19.5 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Exatecan, Alternative-names: DX-8951, CAS# 171335-80-1, Formula: C24H22FN3O4, MWT: 435.4476, Solubility: 10 mM in DMSO, Clinical_Information: Phase 3, Pathway: Cell Cycle/DNA Damage, Target: Topoisomerase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Exatecan (Mesylate), Alternative-names: DX8951f, CAS# 169869-90-3, Formula: C25H26FN3O7S, MWT: 531.5532432, Solubility: DMSO: 15.3 mg/mL, Clinical_Information: Phase 3, Pathway: Cell Cycle/DNA Damage, Target: Topoisomerase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Hoechst 33342 (trihydrochloride), Alternative-names: bisBenzimide H 33342 trihydrochloride;HOE 33342 trihydrochloride, CAS# 875756-97-1, Formula: C27H31Cl3N6O, MWT: 561.9337, Solubility: DMSO: ≥ 46 mg/mL; H<sub>2</sub>O: ≥ 5.6 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pentoxifylline, Alternative-names: PTX;Oxpentifylline, CAS# 6493-05-6, Formula: C13H18N4O3, MWT: 278.307, Solubility: DMSO: ≥ 2.8 mg/mL; H<sub>2</sub>O: 93.3 mg/mL, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease;Autophagy, Target: Phosphodiesterase (PDE);Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Carteolol (hydrochloride), Alternative-names: , CAS# 51781-21-6, Formula: C16H25ClN2O3, MWT: 328.8343, Solubility: DMSO: 13.33 mg/mL, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Adrenergic Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Ramatroban, Alternative-names: BAY u3405, CAS# 116649-85-5, Formula: C21H21FN2O4S, MWT: 416.4659, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Luminol (sodium salt), Alternative-names: , CAS# 20666-12-0, Formula: C8H7N3NaO2+, MWT: 200.1493007, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Talaporfin (sodium), Alternative-names: ME2906;Mono-L-aspartyl chlorin e6;NPe6, CAS# 220201-34-3, Formula: C38H37N5Na4O9, MWT: 799.6876, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Methylene Blue, Alternative-names: Basic Blue 9;Tetramethylthionine chloride;methylthioninium chloride;CI-52015, CAS# 61-73-4, Formula: C16H18ClN3S, MWT: 319.8522, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Sertaconazole (nitrate), Alternative-names: FI7056, CAS# 99592-39-9, Formula: C20H16Cl3N3O4S, MWT: 500.7827, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Fungal, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Fumagillin, Alternative-names: Amebacilin;NSC9168, CAS# 23110-15-8, Formula: C26H34O7, MWT: 458.5439, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Azithromycin (hydrate), Alternative-names: CP-62993 dihydrate, CAS# 117772-70-0, Formula: C38H76N2O14, MWT: 785.015, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: Bacterial;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Gliclazide, Alternative-names: S1702;SE1702, CAS# 21187-98-4, Formula: C15H21N3O3S, MWT: 323.4106, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Hematoporphyrin, Alternative-names: , CAS# 14459-29-1, Formula: C34H38N4O6, MWT: 598.6887, Solubility: DMSO: ≥ 6 mg/mL, Clinical_Information: Phase 1, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fenofibric acid, Alternative-names: FNF acid, CAS# 42017-89-0, Formula: C17H15ClO4, MWT: 318.7516, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;NF-κB, Target: PPAR;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Ibudilast, Alternative-names: KC-404;AV-411;MN-166, CAS# 50847-11-5, Formula: C14H18N2O, MWT: 230.3055, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Metabolic Enzyme/Protease, Target: Phosphodiesterase (PDE), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Bucladesine (sodium salt), Alternative-names: Dibutyryl-cAMP sodium salt;DC2797;Sodium dibutyryl cAMP, CAS# 16980-89-5, Formula: C18H23N5NaO8P, MWT: 491.3675, Solubility: H<sub>2</sub>O: ≥ 42 mg/mL; DMSO: < 7 mg/mL, Clinical_Information: Launched, Pathway: Stem Cell/Wnt;Protein Tyrosine Kinase/RTK, Target: PKA;PKA, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Bicyclol, Alternative-names: SY801, CAS# 118159-48-1, Formula: C19H18O9, MWT: 390.3408, Solubility: DMSO: ≥ 68 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Autophagy, Target: HBV;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 25mg |
| Cefozopran, Alternative-names: SCE-2787, CAS# 113359-04-9, Formula: C19H17N9O5S2, MWT: 515.5256, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Seratrodast, Alternative-names: AA 2414, CAS# 112665-43-7, Formula: C22H26O4, MWT: 354.4395, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein, Target: Prostaglandin Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Ingenol Mebutate, Alternative-names: Ingenol 3-angelate;PEP005, CAS# 75567-37-2, Formula: C25H34O6, MWT: 430.5339, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: TGF-beta/Smad;Epigenetics, Target: PKC;PKC, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| Doxepin (Hydrochloride), Alternative-names: , CAS# 1229-29-4, Formula: C19H22ClNO, MWT: 315.8371, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: Serotonin Transporter, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Pilocarpine (Hydrochloride), Alternative-names: , CAS# 54-71-7, Formula: C11H17ClN2O2, MWT: 244.7179, Solubility: H<sub>2</sub>O: ≥ 37 mg/mL; DMSO: 6.8 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: mAChR;mAChR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Itopride (hydrochloride), Alternative-names: HSR803, CAS# 122892-31-3, Formula: C20H27ClN2O4, MWT: 394.8924, Solubility: DMSO: ≥ 52 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling, Target: AChE, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Zoledronic acid (monohydrate), Alternative-names: Zoledronate monohydrate;CGP 42446 monohydrate;CGP42446A monohydrate;ZOL 446 monohydrate, CAS# 165800-06-6, Formula: C5H12N2O8P2, MWT: 290.1049, Solubility: H<sub>2</sub>O: 28.57 mg/mL (Need ultrasonic), Clinical_Information: Launched, Pathway: TGF-beta/Smad;Epigenetics;Autophagy, Target: PKC;PKC;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| NVP-TNKS656, Alternative-names: TNKS656, CAS# 1419949-20-4, Formula: C27H34N4O5, MWT: 494.5827, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Epigenetics;Cell Cycle/DNA Damage, Target: PARP;PARP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Fotemustine, Alternative-names: S10036, CAS# 92118-27-9, Formula: C9H19ClN3O5P, MWT: 315.691, Solubility: DMSO：≥ 3 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: DNA Alkylator/Crosslinker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Pazufloxacin, Alternative-names: T3761, CAS# 127045-41-4, Formula: C16H15FN2O4, MWT: 318.2997, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Fenoldopam, Alternative-names: SKF 82526, CAS# 67227-56-9, Formula: C16H16ClNO3, MWT: 305.7561, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: GPCR/G Protein;Neuronal Signaling, Target: Dopamine Receptor;Dopamine Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Dithranol, Alternative-names: Anthralin, CAS# 1143-38-0, Formula: C14H10O3, MWT: 226.2274, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Cyclobenzaprine (hydrochloride), Alternative-names: MK130 hydrochloride, CAS# 6202-23-9, Formula: C20H22ClN, MWT: 311.8484, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Neuronal Signaling;GPCR/G Protein, Target: 5-HT Receptor;5-HT Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Eflornithine, Alternative-names: DFMO;MDL71782;RMI71782;α-difluoromethylornithine, CAS# 70052-12-9, Formula: C6H12F2N2O2, MWT: 182.1685, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Eflornithine (hydrochloride), Alternative-names: DFMO hydrochloride;MDL71782 hydrochloride;RMI71782 hydrochloride;α-difluoromethylornithine hydrochloride, CAS# 68278-23-9, Formula: C6H13ClF2N2O2, MWT: 218.6294, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Pirarubicin, Alternative-names: THP, CAS# 72496-41-4, Formula: C32H37NO12, MWT: 627.6357, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Autophagy, Target: Topoisomerase;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Ginsenoside Rg3, Alternative-names: 20(S)-Ginsenoside-Rg3;Rg3;S-Ginsenoside Rg3, CAS# 14197-60-5, Formula: C42H72O13, MWT: 785.0133, Solubility: 10 mM in DMSO, Clinical_Information: Phase 2, Pathway: Membrane Transporter/Ion Channel, Target: Potassium Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Xylitol, Alternative-names: Xylite, CAS# 87-99-0, Formula: C5H12O5, MWT: 152.1458, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: Phase 4, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Irinotecan (hydrochloride), Alternative-names: CPT-11 hydrochloride;Camptothecin 11 hydrochloride, CAS# 100286-90-6, Formula: C33H39ClN4O6, MWT: 623.139, Solubility: DMSO: ≥ 51 mg/mL, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage;Autophagy, Target: Topoisomerase;Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Folinic acid, Alternative-names: leucovorin, CAS# 58-05-9, Formula: C20H23N7O7, MWT: 473.4393, Solubility: DMSO, Clinical_Information: Launched, Pathway: Cell Cycle/DNA Damage, Target: Antifolate, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Baclofen, Alternative-names: , CAS# 1134-47-0, Formula: C10H12ClNO2, MWT: 213.6608, Solubility: DMSO: < 7.8 mg/mL, Clinical_Information: Launched, Pathway: Neuronal Signaling;Membrane Transporter/Ion Channel, Target: GABA Receptor;GABA Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| N-desmethyl Enzalutamide, Alternative-names: N-desmethyl MDV 3100, CAS# 1242137-16-1, Formula: C20H14F4N4O2S, MWT: 450.4094, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Androgen Receptor, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| SM-164, Alternative-names: , CAS# 957135-43-2, Formula: C62H84N14O6, MWT: 1121.421, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Apoptosis, Target: IAP, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Tubulysin A, Alternative-names: TubA, CAS# 205304-86-5, Formula: C43H65N5O10S, MWT: 844.0687, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Cell Cycle/DNA Damage;Cytoskeleton;Antibody-drug Conjugate/ADC Related, Target: Microtubule/Tubulin;Microtubule/Tubulin;ADC Cytotoxin, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| 6-Maleimidohexanoic acid N-hydroxysuccinimide ester, Alternative-names: EMCS, CAS# 55750-63-5, Formula: C14H16N2O6, MWT: 308.2867, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Antibody-drug Conjugate/ADC Related, Target: ADC Linker, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Pulsatilla saponin D, Alternative-names: SB365;Hederacolchiside A, CAS# 68027-15-6, Formula: C47H76O17, MWT: 913.0961, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| (20S)-Protopanaxadiol, Alternative-names: 20-Epiprotopanaxadiol;20(S)-APPD, CAS# 30636-90-9, Formula: C30H52O3, MWT: 460.7321, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Membrane Transporter/Ion Channel, Target: P-glycoprotein, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| (20S)-Protopanaxatriol, Alternative-names: 20(S)-APPT;g-PPT, CAS# 34080-08-5, Formula: C30H52O4, MWT: 476.7315, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Others;Cell Cycle/DNA Damage;GPCR/G Protein;NF-κB, Target: Estrogen Receptor/ERR;PPAR;Glucocorticoid Receptor;PPAR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Rebaudioside C, Alternative-names: Dulcoside B, CAS# 63550-99-2, Formula: C44H70O22, MWT: 951.0134, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Difluprednate, Alternative-names: , CAS# 23674-86-4, Formula: C27H34F2O7, MWT: 508.5515, Solubility: DMSO: ≥ 44 mg/mL, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| Desoximetasone, Alternative-names: , CAS# 382-67-2, Formula: C22H29FO4, MWT: 376.4617, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| Nonivamide, Alternative-names: Pseudocapsaicin;Pelargonic acid vanillylamide;Nonanoic acid vanillylamide, CAS# 2444-46-4, Formula: C17H27NO3, MWT: 293.4012, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Membrane Transporter/Ion Channel, Target: TRP Channel, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Jervine, Alternative-names: 11-Ketocyclopamine, CAS# 469-59-0, Formula: C27H39NO3, MWT: 425.6035, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Stem Cell/Wnt;Stem Cell/Wnt, Target: Hedgehog;Smo, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Veratramine, Alternative-names: NSC17821;NSC23880, CAS# 60-70-8, Formula: C27H39NO2, MWT: 409.6041, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Cephalotaxlen, Alternative-names: (-)-Cephalotaxine;ZINC19795976, CAS# 24316-19-6, Formula: C18H21NO4, MWT: 315.3636, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Quillaic acid, Alternative-names: Quillaja sapogenin, CAS# 631-01-6, Formula: C30H46O5, MWT: 486.6832, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Bruceantin, Alternative-names: (-)-Bruceantin;NCI165563;NSC165563, CAS# 41451-75-6, Formula: C28H36O11, MWT: 548.5789, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Bruceine A, Alternative-names: Dihydrobrusatol;NSC310616, CAS# 25514-31-2, Formula: C26H34O11, MWT: 522.5416, Solubility: DMSO: 12 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Parasite , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Bevirimat, Alternative-names: PA-457;MPC-4326;FH11327;YK FH312, CAS# 174022-42-5, Formula: C36H56O6, MWT: 584.8262, Solubility: DMSO, Clinical_Information: Phase 2, Pathway: Anti-infection, Target: HIV, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| Micheliolide, Alternative-names: , CAS# 68370-47-8, Formula: C15H20O3, MWT: 248.3175, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Arglabin, Alternative-names: (+)-Arglabin, CAS# 84692-91-1, Formula: C15H18O3, MWT: 246.3016, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Immunology/Inflammation, Target: NOD-like Receptor (NLR), HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Kauniolide, Alternative-names: , CAS# 81066-45-7, Formula: C15H18O2, MWT: 230.3022, Solubility: DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| ABTS (diammonium salt), Alternative-names: AzBTS-(NH4)2, CAS# 30931-67-0, Formula: C18H24N6O6S4, MWT: 548.6797, Solubility: H<sub>2</sub>O, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| ADOS, Alternative-names: , CAS# 82692-96-4, Formula: C12H19NNaO5S+, MWT: 312.3371807, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| ADPS, Alternative-names: ESPAS, CAS# 82611-88-9, Formula: C12H18NNaO4S, MWT: 295.3304, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| ALPS, Alternative-names: N-Ethyl-N-sulfopropylaniline sodium salt, CAS# 82611-85-6, Formula: C11H16NNaO3S, MWT: 265.3044, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| AMPPD, Alternative-names: Lumi-Phos Plus;Lumigen PPD;PPD, CAS# 122341-56-4, Formula: C18H23O7P, MWT: 382.3448, Solubility: H<sub>2</sub>O: ≥ 44 mg/mL; DMSO: < 10 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| BBD, Alternative-names: NSC240867;Benzylamino-NBD, CAS# 18378-20-6, Formula: C13H10N4O3, MWT: 270.2435, Solubility: DMSO: ≥ 34 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| PFK-015, Alternative-names: , CAS# 4382-63-2, Formula: C17H12N2O, MWT: 260.29, Solubility: DMSO: 25.2 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| CP-640186, Alternative-names: , CAS# 591778-68-6, Formula: C30H35N3O3, MWT: 485.6172, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Metabolic Enzyme/Protease, Target: Acetyl-CoA Carboxylase, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PTC-209, Alternative-names: , CAS# 315704-66-6, Formula: C17H13Br2N5OS, MWT: 495.191, Solubility: DMSO: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| PTC-209 (hydrobromide), Alternative-names: , CAS# 1217022-63-3, Formula: C17H14Br3N5OS, MWT: 576.103, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| BIBF 1202, Alternative-names: , CAS# 894783-71-2, Formula: C30H31N5O4, MWT: 525.5983, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: No Development Reported, Pathway: Protein Tyrosine Kinase/RTK, Target: VEGFR, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1mg |
| BCA, Alternative-names: Disodium bicinchoninate, CAS# 979-88-4, Formula: C20H10N2Na2O4, MWT: 388.2839, Solubility: DMSO: 15.3 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| BCIP, Alternative-names: BCIP p-toluidine salt;X-phosphate p-toluidine salt, CAS# 6578-06-9, Formula: C15H15BrClN2O4P, MWT: 433.6214, Solubility: DMSO: ≥ 51 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 5-BrdU, Alternative-names: BUdR;BRDU, CAS# 59-14-3, Formula: C9H11BrN2O5, MWT: 307.0981, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: Phase 2, Pathway: Cell Cycle/DNA Damage, Target: Nucleoside Antimetabolite/Analog, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| CNP-AFU, Alternative-names: 2-Chloro-4-nitrophenyl α-L-fucopyranoside, CAS# 157843-41-9, Formula: C12H14ClNO7, MWT: 319.69506, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| DAB, Alternative-names: 3,3' Diaminobenzidine Tetrahydrochloride, CAS# 7411-49-6, Formula: C12H14N4.4HCl, MWT: 360.11, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10g |
| DAOS, Alternative-names: , CAS# 83777-30-4, Formula: C13H20NNaO6S, MWT: 341.3558, Solubility: DMSO: ≥ 36 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| DHBS, Alternative-names: DCHBS, CAS# 54970-72-8, Formula: C6H3Cl2NaO4S, MWT: 265.0464, Solubility: H<sub>2</sub>O: ≥ 32 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| DTNB, Alternative-names: Ellman’s Reagent, CAS# 69-78-3, Formula: C14H8N2O8S2, MWT: 396.35192, Solubility: DMSO: ≥ 43 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| DTE, Alternative-names: Dithioerythritol;Cleland’s reagent, CAS# 6892-68-8, Formula: C4H10O2S2, MWT: 154.251, Solubility: H<sub>2</sub>O: ≥ 100 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| DTT, Alternative-names: DL-Dithiothreitol;Cleland’s reagent, CAS# 3483-12-3, Formula: C4H10O2S2, MWT: 154.251, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: Phase 3, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| FITC, Alternative-names: Fluorescein 5-isothiocyanate, CAS# 3326-32-7, Formula: C21H11NO5S, MWT: 389.3807, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| HDAOS, Alternative-names: , CAS# 82692-88-4, Formula: C11H16NNaO6S, MWT: 313.3026, Solubility: DMSO: 9.8 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| HTBA, Alternative-names: , CAS# 53279-72-4, Formula: C7H3I3O3, MWT: 515.8103, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| INT, Alternative-names: Iodonitrotetrazolium chloride;p-Iodonitrotetrazolium Violet, CAS# 146-68-9, Formula: C19H13ClIN5O2, MWT: 505.69629, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| IPTG, Alternative-names: Isopropyl β-D-thiogalactoside, CAS# 367-93-1, Formula: C9H18O5S, MWT: 238.3012, Solubility: DMSO: ≥ 60 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
Luminol, Alternative-names: Diogenes reagent, CAS# 521-31-3, Formula: C8H7N3O2, MWT: 177.1601, Solubility: DMSO: ≥ 30 mg/mL
, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| MTT, Alternative-names: Thiazolyl Blue;Thiazolyl Blue Tetrazolium Bromide;Methylthiazolyldiphenyl-tetrazolium bromide, CAS# 298-93-1, Formula: C18H16BrN5S, MWT: 414.3221, Solubility: DMSO: ≥ 32 mg/mL; H<sub>2</sub>O: 0.88 mg/mL (Need ultrasonic and warming), Clinical_Information: Phase 4, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| NBT, Alternative-names: Nitro BT;p-Nitrotetrazolium blue;Nitrotetrazolium Blue chloride, CAS# 298-83-9, Formula: C40H30Cl2N10O6, MWT: 817.6356, Solubility: DMSO: 17 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| ONPG, Alternative-names: 2-Nitrophenyl β-D-galactopyranoside, CAS# 369-07-3, Formula: C12H15NO8, MWT: 301.2494, Solubility: H<sub>2</sub>O: 7.4 mg/mL (Need ultrasonic), Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| PNPG, Alternative-names: 4-Nitrophenyl β-D-glucopyranoside, CAS# 2492-87-7, Formula: C12H15NO8, MWT: 301.2494, Solubility: DMSO: ≥ 48 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| PNPP, Alternative-names: , CAS# 4264-83-9, Formula: C6H4NNa2O6P, MWT: 263.05236056, Solubility: H<sub>2</sub>O: ≥ 200 mg/mL, Clinical_Information: No Development Reported, Pathway: , Target: , HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| TBHBA, Alternative-names: 2,4,6-Tribromo-3-hydroxybenzoic acid, CAS# 14348-40-4, Formula: C7H3Br3O3, MWT: 374.8089, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| TMB, Alternative-names: BM blue;Sure Blue TMB;TMB Blotting Plus;TMB substrate, CAS# 54827-17-7, Formula: C16H20N2, MWT: 240.3434, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| TMB (dihydrochloride), Alternative-names: BM blue dihydrochloride;Sure Blue TMB dihydrochloride;TMB Blotting Plus dihydrochloride;TMB substrate dihydrochloride, CAS# 64285-73-0, Formula: C16H20N2, MWT: 240.3434, Solubility: DMSO: ≥ 33 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| PX-12, Alternative-names: IV-2, CAS# 141400-58-0, Formula: C7H12N2S2, MWT: 188.3136, Solubility: DMSO: ≥ 44.7 mg/mL, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5mg |
| TMB-PS, Alternative-names: TMBZ-PS, CAS# 102062-36-2, Formula: C19H26N2O3S, MWT: 362.4863, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| TOOS, Alternative-names: TOOS sodium salt, CAS# 82692-93-1, Formula: C12H18NNaO4S, MWT: 295.3304, Solubility: DMSO: ≥ 47 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| TOPS, Alternative-names: , CAS# 40567-80-4, Formula: C12H18NNaO3S, MWT: 279.331, Solubility: DMSO: ≥ 42 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| X-GAL, Alternative-names: BCIG, CAS# 7240-90-6, Formula: C14H15BrClNO6, MWT: 408.629, Solubility: DMSO: ≥ 39 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| X-Gluc (Dicyclohexylamine), Alternative-names: , CAS# 18656-96-7, Formula: C26H36BrClN2O7, MWT: 603.9302, Solubility: DMSO: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| γ-GT, Alternative-names: , CAS# 63699-78-5, Formula: C12H16N4O7, MWT: 328.278, Solubility: H<sub>2</sub>O: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 5-FAM, Alternative-names: 5-Carboxyfluorescein, CAS# 76823-03-5, Formula: C21H12O7, MWT: 376.3158, Solubility: DMSO: ≥ 31 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| 6-FAM, Alternative-names: 6-Carboxyfluorescein, CAS# 3301-79-9, Formula: C21H12O7, MWT: 376.3158, Solubility: DMSO: ≥ 40 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 5(6)-FAM SE, Alternative-names: 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester;FLUOS;5(6)-Carboxyfluorescein succinimidyl ester mixed isomers, CAS# 117548-22-8, Formula: C25H15NO9, MWT: 473.39, Solubility: H<sub>2</sub>O: ≥ 36 mg/mL; DMSO: 14.3 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| 5-FAM SE, Alternative-names: , CAS# 92557-80-7, Formula: C25H15NO9, MWT: 473.3879, Solubility: DMSO: 25 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| 6-FAM SE, Alternative-names: , CAS# 92557-81-8, Formula: C25H15NO9, MWT: 473.3879, Solubility: DMSO: ≥ 45 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 5(6)-Carboxyfluorescein, Alternative-names: 5(6)-FAM;5-(and-6)-Carboxyfluorescein mixed isomers, CAS# 72088-94-9, Formula: C42H24O14, MWT: 752.63156, Solubility: DMSO: ≥ 41 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 1g |
| 6-FITC, Alternative-names: 6-Fluorescein Isothiocyanate, CAS# 3326-31-6, Formula: C21H11NO5S, MWT: 389.3807, Solubility: DMSO: ≥ 35 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| 5(6)-FITC, Alternative-names: Fluorescein 5(6)-isothiocyanate;FITC;Fluorescein isothiocyanate 5- and 6- isomers, CAS# 27072-45-3, Formula: C21H11NO5S, MWT: 389.38, Solubility: DMSO: ≥ 156 mg/mL, Clinical_Information: Phase 2, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| 5-TAMRA, Alternative-names: 5-Carboxytetramethylrhodamine, CAS# 91809-66-4, Formula: C25H22N2O5, MWT: 430.4526, Solubility: DMSO: ≥ 63 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| 6-TAMRA, Alternative-names: 6-Carboxytetramethylrhodamine, CAS# 91809-67-5, Formula: C25H22N2O5, MWT: 430.4526, Solubility: DMSO: < 4.3 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| 5(6)-TAMRA, Alternative-names: 5(6)-Carboxytetramethylrhodamine, CAS# 98181-63-6, Formula: C25H22N2O5, MWT: 430.45, Solubility: DMSO: 4.3 mg/mL, Clinical_Information: No Development Reported, Pathway: Others, Target: Others, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 200mg |
| Apramycin, Alternative-names: Nebramycin II, CAS# 37321-09-8, Formula: C21H41N5O11, MWT: 539.5771, Solubility: 10 mM in DMSO, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 50mg |
| Bleomycin (sulfate), Alternative-names: , CAS# 9041-93-4, Formula: C55H85N17O25S4, MWT: 1512.622, Solubility: DMSO: < 11.2 mg/mL; H<sub>2</sub>O: 255 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection;Cell Cycle/DNA Damage, Target: Bacterial;DNA/RNA Synthesis, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
| Capreomycin (sulfate), Alternative-names: , CAS# 1405-37-4, Formula: C25H46N14O11S, MWT: 750.7849, Solubility: H<sub>2</sub>O: ≥ 37 mg/mL, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Demeclocycline (hydrochloride), Alternative-names: , CAS# 64-73-3, Formula: C21H22Cl2N2O8, MWT: 501.314, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 100mg |
| G-418 (disulfate), Alternative-names: Geneticin sulfate;Antibiotic G-418 sulfate, CAS# 108321-42-2, Formula: C20H44N4O18S2, MWT: 692.70936, Solubility: H<sub>2</sub>O: ≥ 30 mg/mL, Clinical_Information: No Development Reported, Pathway: Anti-infection, Target: Bacterial, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 5g |
| Heparin, Alternative-names: , CAS# 9005-49-6, Formula: C26H42N2O37S5, MWT: 1134.928, Solubility: 10 mM in H<sub>2</sub>O, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 500mg |
| Tacrolimus (monohydrate), Alternative-names: Fujimycin monohydrate;FR900506 monohydrate;FK506 monohydrate, CAS# 109581-93-3, Formula: C44H71NO13, MWT: 822.0334, Solubility: 10 mM in DMSO, Clinical_Information: Launched, Pathway: Autophagy, Target: Autophagy, HPLC>98%, NMR, LCMS, MSDS, COA is ok, stock more than 10mg |
